@Article{barrenho_inequities_2022,
  author         = {Barrenho, Eliana and Halmai, Réka and Miraldo, Marisa and Tzintzun, Iván and Raïs Ali, Setti and Toulemon, Léa and Dupont, Jean-Claude K. and Rochaix, Lise},
  journal        = {Social Science and Medicine},
  title          = {Inequities in cancer drug development in terms of unmet medical need},
  year           = {2022},
  issn           = {02779536},
  month          = {jun},
  pages          = {114953},
  volume         = {302},
  date           = {2022-06},
  doi            = {10.1016/j.socscimed.2022.114953},
  journaltitle   = {Social Science \& Medicine},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  shortjournal   = {Social Science and Medicine},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0277953622002593},
  urldate        = {2022-05-17},
}

@Article{casali_rare_2022,
  author         = {Casali, P.G. and Licitra, L. and Frezza, A.M. and Trama, A.},
  title          = {‘Rare cancers’: not all together in clinical studies!},
  issn           = {09237534},
  number         = {5},
  pages          = {463--465},
  volume         = {33},
  date           = {2022-05},
  doi            = {10.1016/j.annonc.2022.01.077},
  journaltitle   = {Annals of Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Annals of Oncology},
  shorttitle     = {‘Rare cancers’},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0923753422001041},
  urldate        = {2022-05-17},
}

@Article{hoes_patients_2022,
  author         = {Hoes, Louisa R. and van Berge Henegouwen, Jade M. and van der Wijngaart, Hanneke and Zeverijn, Laurien J. and van der Velden, Daphne L. and van de Haar, Joris and Roepman, Paul and de Leng, Wendy J. and Jansen, Anne M.L. and van Werkhoven, Erik and van der Noort, Vincent and Huitema, Alwin D.R. and Gort, Eelke H. and de Groot, Jan Willem B. and Kerver, Emile D. and de Groot, Derk Jan and Erdkamp, Frans and Beerepoot, Laurens V. and Hendriks, Mathijs P. and Smit, Egbert F. and van der Graaf, Winette T.A. and van Herpen, Carla M.L. and Labots, Mariette and Hoeben, Ann and Morreau, Hans and Lolkema, Martijn P. and Cuppen, Edwin and Gelderblom, Hans and Verheul, Henk M.W. and Voest, Emile E.},
  title          = {Patients with Rare Cancers in the Drug Rediscovery Protocol ({DRUP}) Benefit from Genomics-Guided Treatment},
  issn           = {1078-0432, 1557-3265},
  number         = {7},
  pages          = {1402--1411},
  volume         = {28},
  abstract       = {Abstract
            
              Purpose:
              Patients with rare cancers (incidence less than 6 cases per 100,000 persons per year) commonly have less treatment opportunities and are understudied at the level of genomic targets. We hypothesized that patients with rare cancer benefit from approved anticancer drugs outside their label similar to common cancers.
            
            
              Experimental Design:
              In the Drug Rediscovery Protocol ({DRUP}), patients with therapy-refractory metastatic cancers harboring an actionable molecular profile are matched to {FDA}/European Medicines Agency–approved targeted therapy or immunotherapy. Patients are enrolled in parallel cohorts based on the histologic tumor type, molecular profile and study drug. Primary endpoint is clinical benefit (complete response, partial response, stable disease ≥ 16 weeks).
            
            
              Results:
              Of 1,145 submitted cases, 500 patients, including 164 patients with rare cancers, started one of the 25 available drugs and were evaluable for treatment outcome. The overall clinical benefit rate was 33\% in both the rare cancer and nonrare cancer subgroup. Inactivating alterations of {CDKN}2A and activating {BRAF} aberrations were overrepresented in patients with rare cancer compared with nonrare cancers, resulting in more matches to {CDK}4/6 inhibitors (14\% vs. 4\%; P ≤ 0.001) or {BRAF} inhibitors (9\% vs. 1\%; P ≤ 0.001). Patients with rare cancer treated with small-molecule inhibitors targeting {BRAF} experienced higher rates of clinical benefit (75\%) than the nonrare cancer subgroup.
            
            
              Conclusions:
              Comprehensive molecular testing in patients with rare cancers may identify treatment opportunities and clinical benefit similar to patients with common cancers. Our findings highlight the importance of access to broad molecular diagnostics to ensure equal treatment opportunities for all patients with cancer.},
  date           = {2022-04-01},
  doi            = {10.1158/1078-0432.CCR-21-3752},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\6EXBCBJ6\\Hoes и др. - 2022 - Patients with Rare Cancers in the Drug Rediscovery.pdf:application/pdf},
  journaltitle   = {Clinical Cancer Research},
  langid         = {english},
  qualityassured = {qualityAssured},
  url            = {https://aacrjournals.org/clincancerres/article/28/7/1402/682217/Patients-with-Rare-Cancers-in-the-Drug-Rediscovery},
  urldate        = {2022-05-17},
}

@Article{gatta_rare_2011,
  author         = {Gatta, Gemma and van der Zwan, Jan Maarten and Casali, Paolo G. and Siesling, Sabine and Dei Tos, Angelo Paolo and Kunkler, Ian and Otter, Renée and Licitra, Lisa and Mallone, Sandra and Tavilla, Andrea and Trama, Annalisa and Capocaccia, Riccardo},
  title          = {Rare cancers are not so rare: The rare cancer burden in Europe},
  issn           = {09598049},
  number         = {17},
  pages          = {2493--2511},
  volume         = {47},
  date           = {2011-11},
  doi            = {10.1016/j.ejca.2011.08.008},
  journaltitle   = {European Journal of Cancer},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {European Journal of Cancer},
  shorttitle     = {Rare cancers are not so rare},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0959804911006083},
  urldate        = {2022-05-17},
}

@Article{gatta_burden_2017,
  author         = {Gatta, Gemma and Capocaccia, Riccardo and Botta, Laura and Mallone, Sandra and De Angelis, Roberta and Ardanaz, Eva and Comber, Harry and Dimitrova, Nadya and Leinonen, Maarit K and Siesling, Sabine and van der Zwan, Jan M and Van Eycken, Liesbet and Visser, Otto and Žakelj, Maja P and Anderson, Lesley A and Bella, Francesca and Kaire, Innos and Otter, Renée and Stiller, Charles A and Trama, Annalisa and Hackl, Monika and Henau, Kris and Van Damme, Nancy and Valerianova, Zdravka and Sekerija, Mario and Dušek, Ladislav and Mägi, Margit and Paapsi, Keiu and Malila, Nea and Velten, Michel and Troussard, Xavier and Bouvier, Veronique and Guizard, Anne-Valérie and Bouvier, Anne-Marie and Arveux, Patrick and Maynadié, Marc and Woronoff, Anne-Sophie and Robaszkiewicz, Michel and Baldi, Isabelle and Monnereau, Alain and Tretarre, Brigitte and Colonna, Marc and Molinié, Florence and Bara, Simona and Schvartz, Claire and Lapôtre-Ledoux, Bénédicte and Grosclaude, Pascale and Stabenow, Roland and Luttmann, Sabine and Nennecke, Alice and Engel, Jutta and {SchubertFritschle}, Gabriele and Heidrich, Jan and Holleczek, Bernd and Jónasson, Jón Gunnlaugur and Clough-Gorr, Kerri and Mazzoleni, Guido and Giacomin, Adriano and Sardo, Antonella Sutera and Barchielli, Alessandro and Serraino, Diego and Collarile, Paolo and Pannozzo, Fabio and Ricci, Paolo and Autelitano, Mariangela and Spagnoli, Gianbattista and Fusco, Mario and Usala, Mario and Vitale, Francesco and Michiara, Maria and Tumino, Rosario and Mangone, Lucia and Falcini, Fabio and Ferretti, Stefano and Filiberti, Rosa Angela and Marani, Enza and Caiazzo, Anna Luisa and Iannelli, Arturo and Sensi, Flavio and Piffer, Silvano and Gentilini, Maria and Madeddu, Anselmo and Colanino, Antonino Ziino and Maspero, Sergio and Candela, Pina and Stracci, Fabrizio and Tagliabue, Giovanna and Rugge, Massimo and Baili, Paolo and Minicozzi, Pamela and Sant, Milena and Tereanu, Carmen and Francisci, Silvia and Tavilla, Andrea and Pierannunzio, Daniela and Rossi, Silvia and Santaquilani, Mariano and Knijn, Arnold and Pildava, Santa and Smailyte, Giedre and Calleja, Neville and Agius, Dominic and Johannesen, Tom Børge and Rachtan, Jadwiga and Gózdz, Stanislaw and Blaszczyk, Jerzy and Kepska, Kamila and Lacerda, Gonçalo Forjaz de and Bento, Maria José and Miranda, Ana and Diba, Chakameh Safaei and Žagar, Tina and Almar, Enrique and Larrañaga, Nerea and Munain, Arantza Lopez de and Torrella-Ramos, Ana and García, José María Díaz and Marcos-Gragera, Rafael and Sanchez, Maria Josè and Navarro, Carmen and Salmeron, Diego and Moreno-Iribas, Conchi and Galceran, Jaume and Carulla, Marià and Mousavi, Mohsen and Bouchardy, Christine and Ess, Silvia M. and Bordoni, Andrea and Konzelmann, Isabelle and Rashbass, Jem and Gavin, Anna and Brewster, David H and Huws, Dyfed Wyn and Ho, Vincent {KY} and Benhamou, Ellen},
  title          = {Burden and centralised treatment in Europe of rare tumours: results of {RARECAREnet}—a population-based study},
  issn           = {14702045},
  number         = {8},
  pages          = {1022--1039},
  volume         = {18},
  date           = {2017-08},
  doi            = {10.1016/S1470-2045(17)30445-X},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\TYTFXY5X\\Gatta и др. - 2017 - Burden and centralised treatment in Europe of rare.pdf:application/pdf},
  journaltitle   = {The Lancet Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {The Lancet Oncology},
  shorttitle     = {Burden and centralised treatment in Europe of rare tumours},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S147020451730445X},
  urldate        = {2022-05-17},
}

@Article{matsuda_rare_2020,
  author         = {Matsuda, Tomohiro and Won, Young-Joo and Chun-ju Chiang, {RuRu} and Lim, Jiwon and Saika, Kumiko and Fukui, Keisuke and Lee, Wen-Chung and Botta, Laura and Bernasconi, Alice and Trama, Annalisa},
  title          = {Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia},
  issn           = {18777821},
  pages          = {101702},
  volume         = {67},
  date           = {2020-08},
  doi            = {10.1016/j.canep.2020.101702},
  journaltitle   = {Cancer Epidemiology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Cancer Epidemiology},
  shorttitle     = {Rare cancers are not rare in Asia as well},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1877782120300369},
  urldate        = {2022-05-17},
}

@Article{blay_value_2016,
  author         = {Blay, Jean-Yves and Coindre, Jean-Michel and Ducimetière, Françoise and Ray-Coquard, Isabelle},
  title          = {The value of research collaborations and consortia in rare cancers},
  issn           = {14702045},
  number         = {2},
  pages          = {e62--e69},
  volume         = {17},
  date           = {2016-02},
  doi            = {10.1016/S1470-2045(15)00388-5},
  journaltitle   = {The Lancet Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {The Lancet Oncology},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1470204515003885},
  urldate        = {2022-05-17},
}

@Article{komatsubara_promise_2016,
  author         = {Komatsubara, Kimberly M and Carvajal, Richard D},
  title          = {The promise and challenges of rare cancer research},
  issn           = {14702045},
  number         = {2},
  pages          = {136--138},
  volume         = {17},
  date           = {2016-02},
  doi            = {10.1016/S1470-2045(15)00485-4},
  journaltitle   = {The Lancet Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {The Lancet Oncology},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1470204515004854},
  urldate        = {2022-05-17},
}

@Article{greenlee_occurrence_2010,
  author         = {Greenlee, Robert T. and Goodman, Marc T. and Lynch, Charles F. and Platz, Charles E. and Havener, Lori A. and Howe, Holly L.},
  title          = {The Occurrence of Rare Cancers in U.S. Adults, 1995–2004},
  issn           = {0033-3549, 1468-2877},
  number         = {1},
  pages          = {28--43},
  volume         = {125},
  abstract       = {Objective.
              Rare cancers have been traditionally understudied, reducing the progress of research and hindering decisions for patients, physicians, and policy makers. We evaluated the descriptive epidemiology of rare cancers using a large, representative, population-based dataset from cancer registries in the United States.
            
            
              Methods.
              We analyzed more than 9 million adult cancers diagnosed from 1995 to 2004 in 39 states and two metropolitan areas using the Cancer in North America ({CINA}) dataset, which covers approximately 80\% of the U.S. population. We applied an accepted cancer classification scheme and a published definition of rare (i.e., fewer than 15 cases per 100,000 per year). We calculated age-adjusted incidence rates and rare/non-rare incidence rate ratios using {SEER}*Stat software, with analyses stratified by gender, age, race/ethnicity, and histology.
            
            
              Results.
              Sixty of 71 cancer types were rare, accounting for 25\% of all adult tumors. Rare cancers occurred with greater relative frequency among those who were younger, nonwhite, and of Hispanic ethnicity than among their older, white, or non-Hispanic counterparts.
            
            
              Conclusions.
              Collectively, rare tumors account for a sizable portion of adult cancers, and disproportionately affect some demographic groups. Maturing population-based cancer surveillance data can be an important source for research on rare cancers, potentially leading to a greater understanding of these cancers and eventually to improved treatment, control, and prevention.},
  date           = {2010-01},
  doi            = {10.1177/003335491012500106},
  file           = {:greenlee_occurrence_2010 - The Occurrence of Rare Cancers in U.S. Adults, 1995–2004.pdf:PDF},
  journaltitle   = {Public Health Reports},
  langid         = {english},
  qualityassured = {qualityAssured},
  readstatus     = {read},
  shortjournal   = {Public Health Rep},
  url            = {http://journals.sagepub.com/doi/10.1177/003335491012500106},
  urldate        = {2022-05-17},
}

@Article{tamaki_burden_2014,
  author         = {Tamaki, Tomoko and Dong, Yiqi and Ohno, Yuko and Sobue, Tomotaka and Nishimoto, Hiroshi and Shibata, Akiko},
  title          = {The burden of rare cancer in Japan: Application of the {RARECARE} definition},
  issn           = {18777821},
  number         = {5},
  pages          = {490--495},
  volume         = {38},
  date           = {2014-10},
  doi            = {10.1016/j.canep.2014.07.014},
  journaltitle   = {Cancer Epidemiology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Cancer Epidemiology},
  shorttitle     = {The burden of rare cancer in Japan},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1877782114001404},
  urldate        = {2022-05-17},
}

@Article{the_lancet_oncology_very_2001,
  author         = {The Lancet Oncology},
  title          = {Very rare cancers — a problem neglected},
  issn           = {14702045},
  number         = {4},
  pages          = {189},
  volume         = {2},
  date           = {2001-04},
  doi            = {10.1016/S1470-2045(00)00273-4},
  journaltitle   = {The Lancet Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  readstatus     = {read},
  shortjournal   = {The Lancet Oncology},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1470204500002734},
  urldate        = {2022-05-17},
}

@Article{sokolowski_proof--concept_2014,
  author         = {Sokolowski, E and Turina, C B and Kikuchi, K and Langenau, D M and Keller, C},
  title          = {Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma},
  issn           = {0950-9232, 1476-5594},
  number         = {15},
  pages          = {1877--1889},
  volume         = {33},
  date           = {2014-04-10},
  doi            = {10.1038/onc.2013.129},
  journaltitle   = {Oncogene},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Oncogene},
  shorttitle     = {Proof-of-concept rare cancers in drug development},
  url            = {https://www.nature.com/articles/onc2013129},
  urldate        = {2022-05-17},
}

@Article{bilkey_descriptive_2021,
  author         = {Bilkey, Gemma A. and Trevithick, Richard W. and Coles, Emily P. and Girschik, Jennifer and Nowak, Kristen J.},
  title          = {Descriptive epidemiological study of rare, less common and common cancers in Western Australia},
  issn           = {1471-2407},
  number         = {1},
  pages          = {779},
  volume         = {21},
  abstract       = {Abstract
            
              Background
              There are no epidemiological studies describing rare cancers in Western Australia ({WA}). We aimed to fill this gap by estimating the incidence and five-year survival of rare, less common and common cancers in {WA}, based on definitions for rarity used by the Australian Institute of Health and Welfare and cancer groupings from the project on Surveillance of Rare Cancers in Europe ({RARECARE}). This research will enable policy- and decision-makers to better understand the size and nature of the public health problem presented by rare cancers in {WA}. It is anticipated that this study will inform improved health service design and delivery for all {WA} cancer patients, but particularly those with rare and less common cancers.
            
            
              Methods
              We estimated incidence and five-year survival rates of rare, less common and common cancers in {WA} using data sourced from the {WA} Cancer Registry for the 2013–2017 period. Cancers were defined as rare ({\textless} 6), less common (6–12), or common ({\textgreater} 12) based on their crude incidence rate per 100,000 people per year.
            
            
              Results
              Rare cancers make up 21.5\% of all cancer diagnoses in {WA}, with a significantly poorer five-year survival of 58.2\% (95\% confidence interval ({CI}) 57.3–59.1\%), compared to patients diagnosed with a common cancer, whose five-year survival was 87.8\% (95\% {CI} 87.3–88.3\%). Survival for less common cancers was significantly poorer than both rare and common cancers, at 48.1\% (95\% {CI} 47.3–49.0\%). Together, rare and less common cancers represent 48.4\% of all cancer diagnoses in {WA}.
            
            
              Conclusions
              While rare cancers are individually scarce, collectively over one in five cancer patients in {WA} are diagnosed with a rare cancer. These patients experience significantly worse prognoses compared to patients with common cancers.},
  date           = {2021-12},
  doi            = {10.1186/s12885-021-08501-4},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\Y44JGW4I\\Bilkey и др. - 2021 - Descriptive epidemiological study of rare, less co.pdf:application/pdf},
  journaltitle   = {{BMC} Cancer},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {{BMC} Cancer},
  url            = {https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08501-4},
  urldate        = {2022-05-17},
}

@Article{de_heus_differences_2021,
  author         = {de Heus, Eline and Engelen, Vivian and Dingemans, Irene and Richel, Carol and Schrieks, Marga and van der Zwan, Jan Maarten and Besselink, Marc G. and van Berge Henegouwen, Mark I. and van Herpen, Carla M. L. and Duijts, Saskia F. A.},
  title          = {Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey},
  issn           = {1750-1172},
  number         = {1},
  pages          = {249},
  volume         = {16},
  abstract       = {Abstract
            
              Background
              Patients with rare cancers face challenges in the diagnostic and treatment phase, and in access to clinical expertise. Since studies on health care experiences of these patients in comparison to patients with more common cancers are scarce, we aimed to explore these differences.
            
            
              Methods
              Data were cross-sectionally collected among (former) adult cancer patients through a national online survey in the Netherlands (October 2019). Descriptive statistics were reported and subgroups (rare vs. common patients) were compared.
            
            
              Results
              
                In total, 7343 patients (i.e., 1856 rare and 5487 common cancer patients) participated. Rare cancer patients were more often diagnosed and treated in different hospitals compared to common cancer patients (67\% vs. 59\%,
                p
                 {\textless} 0.001). Rare cancer patients received treatment more often in a single hospital (60\% vs. 57\%,
                p
                 = 0.014), but reported more negative experiences when treated in multiple hospitals than common cancer patients (14\% vs. 9\%,
                p
                 {\textless} 0.001). They also more often received advise from their physician about the hospital to go to for a second opinion (50\% vs. 36\%,
                p
                 {\textless} 0.001), were more likely to choose a hospital specialized in their cancer type (33\% vs. 22\%,
                p
                 {\textless} 0.001), and were more willing to travel as long as necessary to receive specialized care than common cancer patients (55\% vs. 47\%,
                p
                 {\textless} 0.001).
              
            
            
              Conclusions
              Rare and common cancer patients differ in their health care experiences. Health care for rare cancer patients can be further improved by proper referral to centers of expertise and building a clinical network specifically for rare cancers.},
  date           = {2021-12},
  doi            = {10.1186/s13023-021-01886-2},
  file           = {:de_heus_differences_2021 - Differences in Health Care Experiences between Rare Cancer and Common Cancer Patients_ Results from a National Cross Sectional Survey.pdf:PDF;Full Text:C\:/Users/Kostadin/Zotero/storage/8UUPFCZW/de Heus и др. - 2021 - Differences in health care experiences between rar.pdf:application/pdf},
  journaltitle   = {Orphanet Journal of Rare Diseases},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Orphanet J Rare Dis},
  shorttitle     = {Differences in health care experiences between rare cancer and common cancer patients},
  url            = {https://ojrd.biomedcentral.com/articles/10.1186/s13023-021-01886-2},
  urldate        = {2022-05-17},
}

@Article{duijts_rare_2021,
  author         = {Duijts, Saskia F. A. and Zwan, Jan Maarten},
  title          = {Rare cancers and cancer of unknown primary: Here's what you should know!},
  issn           = {0961-5423, 1365-2354},
  number         = {6},
  volume         = {30},
  date           = {2021-11},
  doi            = {10.1111/ecc.13508},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\FSWDVGUQ\\Duijts и Zwan - 2021 - Rare cancers and cancer of unknown primary Here's.pdf:application/pdf},
  journaltitle   = {European Journal of Cancer Care},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Eur J Cancer Care},
  shorttitle     = {Rare cancers and cancer of unknown primary},
  url            = {https://onlinelibrary.wiley.com/doi/10.1111/ecc.13508},
  urldate        = {2022-05-17},
}

@Article{bustamante-teixeira_incidence_2019,
  author         = {Bustamante-Teixeira, Maria Teresa and Latorre, Maria do Rosário D.O. and Guerra, Maximiliano R. and Tanaka, Luana F. and Botta, Laura and Trama, Annalisa and Gatta, Gemma},
  title          = {Incidence of rare cancers in the city of São Paulo, Brazil},
  issn           = {0300-8916, 2038-2529},
  number         = {1},
  pages          = {22--30},
  volume         = {105},
  abstract       = {Introduction:
              Rare cancers are a challenge for clinical practice as well as for epidemiology and public health. Studies on this subject are few and limited to the study of cases with scarce epidemiologic information. This study aimed to evaluate the incidence of rare cancers and to compare the demographic, anatomic, and histologic characteristics of rare and nonrare (common) cancers.
            
            
              Methods:
              Incidence data were obtained from the Population-based Cancer Registry of São Paulo, Brazil. Rare neoplasms were those defined in the {RARECARE} list, which takes into account an incidence lower than 6/100,000/year.
            
            
              Results:
              In São Paulo, 20.4\% of tumors had an incidence lower than 6/100,000/year from 1997 to 2012, being therefore considered as rare tumors. We identified 11 entities with an incidence greater than 6/100,000/year (common neoplasms) and 186 entities with an incidence lower than 6/100,000/year (rare neoplasms). The mean annual incidence of all cancers was 365 per 100,000 in São Paulo between 1997 and 2012, and the incidence of all rare tumors was 74.5 per 100,000.
            
            
              Conclusions:
              This study presents the burden of rare cancers in Brazil. It is expected to be an incentive for further studies of these entities in order to know the epidemiologic profile of rare tumors in Brazil and to provide a more effective diagnostic and therapeutic approach.},
  date           = {2019-02},
  doi            = {10.1177/0300891618821039},
  journaltitle   = {Tumori Journal},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Tumori},
  url            = {http://journals.sagepub.com/doi/10.1177/0300891618821039},
  urldate        = {2022-05-17},
}

@Article{graf_von_der_schulenburg_rare_2017,
  author         = {Graf von der Schulenburg, J.-Matthias and Pauer, Frédéric},
  title          = {Rare cancers—Rarity as a cost and value argument},
  issn           = {22135383},
  pages          = {54--59},
  volume         = {11},
  date           = {2017-03},
  doi            = {10.1016/j.jcpo.2016.09.004},
  journaltitle   = {Journal of Cancer Policy},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Journal of Cancer Policy},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S2213538316300194},
  urldate        = {2022-05-17},
}

@Article{__2018,
  author         = {Искров, Георги and Стефанов, Румен},
  journal        = {Редки болести и лекарства сираци},
  title          = {Редките тумори – епидемиологични и общественоздравни аспекти},
  year           = {2018},
  issn           = {1314-3581},
  month          = dec,
  number         = {4},
  pages          = {9--13},
  volume         = {9},
  abstract       = {Редките злокачествени заболявания, наричани накратко редки тумори, са все по-популярна тема от научноизследователска, клинична и общественоздравна гледна точка. Злокачествените новообразувания сами по себе си представляват основен приоритет в съвременното здравеопазване и нозологична категория с огромна социална значимост. Следвайки обаче модела на редките болести, в научните среди все повече се говори за редките тумори. Съчетавайки медико-социалната парадигма на редките заболявания с клиничния профил на онкологията, редките тумори имат потенциал да бъдат самостоятелна област за действие с изключително висока степен на добавена стойност. 
Настоящата публикация има за цел да обобщи основните епидемиологични концепции по отношение на редките злокачествени заболявания и да обсъди мястото им в здравната политика.},
  doi            = {10.36865/2018.v9i4.59},
  file           = {Full Text:C\:/Users/Kostadin/Zotero/storage/P2VMSXEF/Искров и Стефанов - 2018 - Редките тумори – епидемиологични и общественоздрав.pdf:application/pdf;:./MEGAsync/phd/pdf/iskrov_rare_tumors.pdf:PDF},
  qualityassured = {qualityAssured},
  shortjournal   = {Редки болести и лекарства сираци},
  url            = {http://journal.raredis.org/index.php/RBLS/article/view/59},
  urldate        = {2022-05-17},
}

@Article{keat_international_2013,
  author         = {Keat, Nicola and Law, Kate and Seymour, Matthew and Welch, Jack and Trimble, Ted and Lascombe, Denis and Negrouk, Anastassia},
  title          = {International Rare Cancers Initiative},
  issn           = {14702045},
  number         = {2},
  pages          = {109--110},
  volume         = {14},
  date           = {2013-02},
  doi            = {10.1016/S1470-2045(12)70570-3},
  journaltitle   = {The Lancet Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {The Lancet Oncology},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1470204512705703},
  urldate        = {2022-05-17},
}

@Article{shrivastava_cancer_2017,
  author         = {Shrivastava, {ShyamKishore}},
  title          = {Cancer research: Challenges and promise for individualized treatment},
  issn           = {0973-0168},
  number         = {2},
  pages          = {91},
  volume         = {8},
  date           = {2017},
  doi            = {10.4103/jrcr.jrcr_26_17},
  journaltitle   = {Journal of Radiation and Cancer Research},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {J Radiat Cancer Res},
  shorttitle     = {Cancer research},
  url            = {http://www.journalrcr.org/text.asp?2017/8/2/91/208031},
  urldate        = {2022-05-17},
}

@Article{konsulova_2021,
  author       = {Консулова, Ася and Йорданов, Ангел and Ел Шемери, Самър and Калчев, Калин and Стоева, Таня and Чаушева, Росица and Данчева, Живка and Спасов, Христо},
  journal      = {Редки болести и лекарства сираци},
  title        = {Колко редки са редките онкологични болести?},
  year         = {2021},
  month        = {Aug.},
  number       = {2},
  pages        = {19-22},
  volume       = {12},
  abstractnote = {&lt;p&gt;Развитието на технологиите, молекулярната генетика и фармакологичната индустрия доведе до подобряване на лечебно-диагностичния процес в медицината. В онкологията през последните десетилетия много фатални в миналото диагнози се превърнаха в излечими или хронично протичащи болести. Това, обаче, не винаги е така при редките онкологични болести. Въпреки разминаването в различните определения за редки онкологични болести, епидемиологични данни сочат, че взети заедно, те съставляват над 20% от всички онкологични диагнози.&lt;/p&gt; &lt;p&gt;Обобщението на данните за тези редки нозологии в онкологията е ключово за тяхната по-добра диагноза, лечение. Известно е и, че тяхната регистрация е субоптимална, особено в страните от Източна Европа. Водещите проблеми в онкологията са свързани с диагнозата и откриването на туморите, за разлика от другите редки неонкологични болести и това влошава много клинични параметри. Вече има данни за удължаване на преживяемостта и подобряване на много клинични резултати при лечение и проследяване в специализирани центрове, поради което експертното поведение в специализирани центрове е силно препоръчително. Вече е изграден и концептуален модел за функциониращ специализиран център, към който да се стремят всички държави.&lt;/p&#38;gt;},
  doi          = {10.36865/2021.v12i2.142},
  url          = {https://journal.raredis.org/index.php/RBLS/article/view/142},
}

@Article{raghavan_structured_2013,
  author         = {Raghavan, D.},
  title          = {A structured approach to uncommon cancers: what should a clinician do?},
  issn           = {09237534},
  number         = {12},
  pages          = {2932--2934},
  volume         = {24},
  date           = {2013-12},
  doi            = {10.1093/annonc/mdt432},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\DXTQMCHK\\Raghavan - 2013 - A structured approach to uncommon cancers what sh.pdf:application/pdf},
  journaltitle   = {Annals of Oncology},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Annals of Oncology},
  shorttitle     = {A structured approach to uncommon cancers},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0923753419367523},
  urldate        = {2022-05-17},
}

@Article{jin_bayesian_2020,
  author         = {Jin, Jin and Riviere, Marie‐Karelle and Luo, Xiaodong and Dong, Yingwen},
  title          = {Bayesian methods for the analysis of early‐phase oncology basket trials with information borrowing across cancer types},
  issn           = {0277-6715, 1097-0258},
  number         = {25},
  pages          = {3459--3475},
  volume         = {39},
  date           = {2020-11-10},
  doi            = {10.1002/sim.8675},
  file           = {:jin_bayesian_2020 - Bayesian Methods for the Analysis of Early‐phase Oncology Basket Trials with Information Borrowing across Cancer Types.pdf:PDF;Submitted Version:C\:/Users/Kostadin/Zotero/storage/3RFTJGTT/Jin и др. - 2020 - Bayesian methods for the analysis of early‐phase o.pdf:application/pdf},
  journaltitle   = {Statistics in Medicine},
  langid         = {english},
  qualityassured = {qualityAssured},
  shortjournal   = {Statistics in Medicine},
  url            = {https://onlinelibrary.wiley.com/doi/10.1002/sim.8675},
  urldate        = {2022-05-17},
}

@Article{gatta2010burden,
  author     = {Gatta, Gemma and Capocaccia, Riccardo and Trama, Annalisa and Mart{\'\i}nez-Garc{\'\i}a, Carmen},
  journal    = {Rare Diseases Epidemiology},
  title      = {The burden of rare cancers in Europe},
  year       = {2010},
  pages      = {285--303},
  booktitle  = {Rare Diseases Epidemiology},
  doi        = {https://doi.org/10.1007/978-90-481-9485-8_17},
  publisher  = {Springer Netherlands},
  readstatus = {read},
  relevance  = {relevant},
}

@Misc{ESMORare82:online,
  author       = {European Society for Medical Oncology},
  howpublished = {\url{https://www.esmo.org/content/download/16802/296577/1/ESMO_Rare_Cancers_recommendations_2010.pdf}},
  note         = {(Accessed on 08/13/2022)},
  title        = {ESMO Rare Cancers recommendations 2010},
  year         = {2008},
  readstatus   = {read},
  relevance    = {relevant},
}

@Article{Boyd2016,
  author    = {Niki Boyd and Janet E Dancey and C Blake Gilks and David G Huntsman},
  journal   = {The Lancet Oncology},
  title     = {Rare cancers: a sea of opportunity},
  year      = {2016},
  month     = {feb},
  number    = {2},
  pages     = {e52--e61},
  volume    = {17},
  doi       = {10.1016/s1470-2045(15)00386-1},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Billingham2016,
  author    = {Lucinda Billingham and Kinga Malottki and Neil Steven},
  journal   = {The Lancet Oncology},
  title     = {Research methods to change clinical practice for patients with rare cancers},
  year      = {2016},
  month     = {feb},
  number    = {2},
  pages     = {e70--e80},
  volume    = {17},
  doi       = {10.1016/s1470-2045(15)00396-4},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Hiripi2012,
  author    = {E. Hiripi and A. Gondos and K. Emrich and B. Holleczek and A. Katalinic and S. Luttmann and E. Sirri and H. Brenner},
  journal   = {Annals of Oncology},
  title     = {Survival from common and rare cancers in Germany in the early 21st century},
  year      = {2012},
  month     = {feb},
  number    = {2},
  pages     = {472--479},
  volume    = {23},
  doi       = {10.1093/annonc/mdr131},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Dijk2012,
  author    = {B.A.C. Van Dijk and G. Gatta and R. Capocaccia and D. Pierannunzio and P. Strojan and L. Licitra},
  journal   = {European Journal of Cancer},
  title     = {Rare cancers of the head and neck area in Europe},
  year      = {2012},
  month     = {apr},
  number    = {6},
  pages     = {783--796},
  volume    = {48},
  doi       = {10.1016/j.ejca.2011.08.021},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Tan2003,
  author     = {S.-B. Tan},
  journal    = {{BMJ}},
  title      = {Strategy for randomised clinical trials in rare cancers},
  year       = {2003},
  month      = {jul},
  number     = {7405},
  pages      = {47--49},
  volume     = {327},
  doi        = {10.1136/bmj.327.7405.47},
  publisher  = {{BMJ}},
  readstatus = {read},
  relevance  = {relevant},
}

@Article{Gatta2019,
  author    = {G. Gatta and A. Trama and R. Capocaccia and Monika Hackl and Elizabeth Van Eycken and Kris Henau and Nadya Dimitrova and Mario Sekerija and Ladislav Du{\v{s}}ek and Margit Mägi and Nea Malila and Maarit Leinonen and Michel Velten and Xavier Troussard and Veronique Bouvier and Anne-Val{\'{e}}rie Guizard and Anne-Marie Bouvier and Patrick Arveux and Marc Maynadi{\'{e}} and Anne-Sophie Woronoff and Michel Robaszkiewicz and Isabelle Baldi and Alain Monnereau and Brigitte Tretarre and Marc Colonna and Florence Molini{\'{e}} and Simona Bara and Claire Schvartz and B{\'{e}}n{\'{e}}dicte Lap{\^{o}}tre-Ledoux and Pascale Grosclaude and Roland Stabenow and Sabine Luttmann and Alice Nennecke and Jutta Engel and Gabriele Schubert-Fritschle and Jan Heidrich and Bernd Holleczek and J{\'{o}}n Gunnlaugur J{\'{o}}nasson and Kerri Clough-Gorr and Harry Comber and Guido Mazzoleni and Adriano Giacomin and Antonella Sutera Sardo and Alessandro Barchielli and Diego Serraino and Roberta De Angelis and Sandra Mallone and Andrea Tavilla and Daniela Pierannunzio and Silvia Rossi and Mariano Santaquilani and Arnold Knijn and Fabio Pannozzo and Valerio Gennaro and Lucia Benfatto and Paolo Ricci and Mariangela Autelitano and Gianbattista Spagnoli and Mario Fusco and Mario Usala and Francesco Vitale and Maria Michiara and Rosario Tumino and Lucia Mangone and Fabio Falcini and Stefano Ferretti and Rosa Angela Filiberti and Enza Marani and Arturo Iannelli and Flavio Sensi and Silvano Piffer and Maria Gentilini and Anselmo Madeddu and Antonio Ziino and Sergio Maspero and Pina Candela and Fabrizio Stracci and Giovanna Tagliabue and Massimo Rugge and Annalisa Trama and Gemma Gatta and Laura Botta and Riccardo Capocaccia and Santa Pildava and Giedre Smailyte and Neville Calleja and Tom B{\o}rge Johannesen and Jadwiga Rachtan and Stanis{\l}aw G{\'{o}}{\'{z}}d{\'{z}} and Jerzy B{\l}aszczyk and Kamila K{\k{e}}pska and Forjaz de Lacerda and Maria Jos{\'{e}} Bento and Ana Miranda and Chakameh Safaei Diba and Enrique Almar and Nerea Larra{\~{n}}aga and Arantza Lopez de Munain and Ana Torrella-Ramos and Jos{\'{e}} Mar{\'{\i}}a D{\'{\i}}az Garc{\'{\i}}a and Rafael Marcos-Gragera and Maria Jos{\`{e}} Sanchez and Carmen Navarro and Diego Salmeron and Conchi Moreno-Iribas and Jaume Galceran and Mari{\`{a}} Carulla and Mohsen Mousavi and Christine Bouchardy and Silvia M. Ess and Andrea Bordoni and Isabelle Konzelmann and Jem Rashbass and Anna Gavin and David H. Brewster and Dyfed Wyn Huws and Otto Visser and Magdalena Bielska-Lasota and Maja Primic-Zakelj and Ian Kunkler and Ellen Benhamou},
  journal   = {European Journal of Surgical Oncology},
  title     = {Epidemiology of rare cancers and inequalities in oncologic outcomes},
  year      = {2019},
  month     = {jan},
  number    = {1},
  pages     = {3--11},
  volume    = {45},
  doi       = {10.1016/j.ejso.2017.08.018},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Charbotel2014,
  author    = {B. Charbotel and B. Fervers and J.P. Droz},
  journal   = {Critical Reviews in Oncology/Hematology},
  title     = {Occupational exposures in rare cancers: A critical review of the literature},
  year      = {2014},
  month     = {may},
  number    = {2},
  pages     = {99--134},
  volume    = {90},
  doi       = {10.1016/j.critrevonc.2013.12.004},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{RayCoquard2017,
  author    = {Isabelle Ray-Coquard and Eric Pujade Lauraine and Axel Le Cesne and Patricia Pautier and Marie Cecile Vacher Lavenue and Annalisa Trama and Paolo Casali and Jean Michel Coindre and Jean Yves Blay},
  journal   = {European Journal of Cancer},
  title     = {Improving treatment results with reference centres for~rare cancers: where do we stand?},
  year      = {2017},
  month     = {may},
  pages     = {90--98},
  volume    = {77},
  doi       = {10.1016/j.ejca.2017.02.006},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Zwan2013,
  author    = {Jan Maarten van der Zwan and Annalisa Trama and Ren{\'{e}}e Otter and Nerea Larra{\~{n}}aga and Andrea Tavilla and Rafael Marcos-Gragera and Angelo Paolo Dei Tos and Eric Baudin and Graeme Poston and Thera Links},
  journal   = {European Journal of Cancer},
  title     = {Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project},
  year      = {2013},
  month     = {jul},
  number    = {11},
  pages     = {2565--2578},
  volume    = {49},
  doi       = {10.1016/j.ejca.2013.02.029},
  file      = {:Zwan2013 - Rare Neuroendocrine Tumours_ Results of the Surveillance of Rare Cancers in Europe Project.pdf:PDF},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Frezza2019,
  author    = {Anna Maria Frezza and Annalisa Trama and Jean-Yves Blay and Paolo G. Casali},
  journal   = {European Journal of Surgical Oncology},
  title     = {Networking in rare cancers: What was done, what is next?},
  year      = {2019},
  month     = {jan},
  number    = {1},
  pages     = {16--18},
  volume    = {45},
  doi       = {10.1016/j.ejso.2018.03.030},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Botta2020,
  author    = {Laura Botta and Gemma Gatta and Annalisa Trama and Alice Bernasconi and Elad Sharon and Riccardo Capocaccia and Angela B. Mariotto and},
  journal   = {Cancer Medicine},
  title     = {Incidence and survival of rare cancers in the {US} and Europe},
  year      = {2020},
  month     = {may},
  number    = {15},
  pages     = {5632--5642},
  volume    = {9},
  doi       = {10.1002/cam4.3137},
  publisher = {Wiley},
  relevance = {relevant},
}

@Article{Rosell2019,
  author    = {Linn Rosell and Jessica Wihl and Oskar Hagberg and Björn Ohlsson and Mef Nilbert},
  journal   = {Rare Tumors},
  title     = {Function, information, and contributions: An evaluation of national multidisciplinary team meetings for rare cancers},
  year      = {2019},
  month     = {jan},
  pages     = {203636131984169},
  volume    = {11},
  doi       = {10.1177/2036361319841696},
  publisher = {{SAGE} Publications},
}

@Article{Buller2021,
  author    = {Ian D Buller and Rena R Jones},
  journal   = {American Journal of Epidemiology},
  title     = {Invited Commentary: Predicting Incidence Rates of Rare Cancers{\textemdash}Adding Epidemiologic and Spatial Contexts},
  year      = {2021},
  month     = {dec},
  number    = {3},
  pages     = {499--502},
  volume    = {191},
  doi       = {10.1093/aje/kwab285},
  publisher = {Oxford University Press ({OUP})},
}

@Article{Munoz2012,
  author         = {Munoz, Javier and Kurzrock, Razelle},
  journal        = {Nature Reviews Clinical Oncology},
  title          = {Targeted therapy in rare cancers—adopting the orphans},
  year           = {2012},
  issn           = {1759-4774, 1759-4782},
  month          = {sep},
  number         = {11},
  pages          = {631--642},
  volume         = {9},
  date           = {2012-11},
  doi            = {10.1038/nrclinonc.2012.160},
  journaltitle   = {Nature Reviews Clinical Oncology},
  langid         = {english},
  publisher      = {Springer Science and Business Media {LLC}},
  qualityassured = {qualityAssured},
  shortjournal   = {Nat Rev Clin Oncol},
  url            = {http://www.nature.com/articles/nrclinonc.2012.160},
  urldate        = {2022-05-17},
}

@Article{Salmeron2021,
  author    = {Diego Salmer{\'{o}}n and Laura Botta and Jos{\'{e}} Miguel Mart{\'{\i}}nez and Annalisa Trama and Gemma Gatta and Josep M Borr{\`{a}}s and Riccardo Capocaccia and Ramon Cl{\`{e}}ries and},
  journal   = {American Journal of Epidemiology},
  title     = {Estimating Country-Specific Incidence Rates of Rare Cancers: Comparative Performance Analysis of Modeling Approaches Using European Cancer Registry Data},
  year      = {2021},
  month     = {oct},
  number    = {3},
  pages     = {487--498},
  volume    = {191},
  doi       = {10.1093/aje/kwab262},
  file      = {:Salmeron2021 - Estimating Country Specific Incidence Rates of Rare Cancers_ Comparative Performance Analysis of Modeling Approaches Using European Cancer Registry Data.pdf:PDF},
  publisher = {Oxford University Press ({OUP})},
}

@Article{Trama2016,
  author    = {Annalisa Trama and Rafael Marcos-Gragera and Maria Jos{\`{e}} S{\'{a}}nchez P{\'{e}}rez and Jan Maarten van der Zwan and Eva Ardanaz and Christine Bouchardy and Juan Manuel Melchor and Carmen Martinez and Riccardo Capocaccia and Massimo Vicentini and Sabine Siesling and Gemma Gatta and},
  journal   = {Tumori Journal},
  title     = {Data Quality in Rare Cancers Registration: The Report of the {RARECARE} Data Quality Study},
  year      = {2016},
  month     = {mar},
  number    = {1},
  pages     = {22--32},
  volume    = {103},
  doi       = {10.5301/tj.5000559},
  publisher = {{SAGE} Publications},
}

@Article{DArcy2020,
  author    = {Monica E D'Arcy and David Castenson and Charles F Lynch and Amy R Kahn and Lindsay M Morton and Meredith S Shiels and Ruth M Pfeiffer and Eric A Engels},
  journal   = {{JNCI}: Journal of the National Cancer Institute},
  title     = {Risk of Rare Cancers Among Solid Organ Transplant Recipients},
  year      = {2020},
  month     = {may},
  doi       = {10.1093/jnci/djaa078},
  publisher = {Oxford University Press ({OUP})},
}

@Article{Bisogno2012,
  author    = {G. Bisogno and A. Ferrari and E. Bien and I. Brecht and B. Brennan and G. Cecchetto and J. Godzinski and D. Orbach and Y. Reguerre and T. Stachowicz-Stencel and D. Schneider},
  journal   = {Klinische Pädiatrie},
  title     = {Rare Cancers in Children {\textendash} The {EXPeRT} Initiative: A Report from the European Cooperative Study Group on Pediatric Rare Tumors},
  year      = {2012},
  month     = {nov},
  number    = {06},
  pages     = {416--420},
  volume    = {224},
  doi       = {10.1055/s-0032-1327608},
  publisher = {Georg Thieme Verlag {KG}},
}

@Article{Sandrucci2019,
  author    = {Sergio Sandrucci and Gemma Gatta},
  journal   = {European Journal of Surgical Oncology},
  title     = {Rare cancers: A network for better care},
  year      = {2019},
  month     = {jan},
  number    = {1},
  pages     = {1--2},
  volume    = {45},
  doi       = {10.1016/j.ejso.2018.06.028},
  publisher = {Elsevier {BV}},
}

@Article{Gallicchio2021,
  author    = {Lisa Gallicchio and Danielle L. Daee and Melissa Rotunno and Rolando Barajas and Sarah Fagan and Danielle M. Carrick and Rao L. Divi and Kelly K. Filipski and Andrew N. Freedman and Elizabeth M. Gillanders and Tram K. Lam and Damali N. Martin and Scott Rogers and Mukesh Verma and Stefanie A. Nelson},
  journal   = {Cancer Epidemiology, Biomarkers {\&}amp$\mathsemicolon$ Prevention},
  title     = {Epidemiologic Research of Rare Cancers: Trends, Resources, and Challenges},
  year      = {2021},
  month     = {apr},
  number    = {7},
  pages     = {1305--1311},
  volume    = {30},
  doi       = {10.1158/1055-9965.epi-20-1796},
  publisher = {American Association for Cancer Research ({AACR})},
}

@Article{iskrov_stefanov_2022,
  author       = {Искров, Георги and Стефанов, Румен},
  journal      = {Редки болести и лекарства сираци},
  title        = {Към нов подход при оценка на лекарствата сираци в Германия},
  year         = {2022},
  month        = {Feb},
  number       = {4},
  pages        = {3-4},
  volume       = {12},
  abstractnote = {&lt;p&gt;Традиционно, подходът при оценка на лекарствата сираци в Германия спада към т.нар. модел с фокус върху добавените здравни ползи. Това означава, че водещ критерий при вземане на решение за заплащане с публични средства е не разходната ефективност (както например е във Великобритания), а допълнителните здравни резултати на новата терапия спрямо алтернативата за сравнение. Привържениците на тази методология смятат за нейно основно предимство бързия достъп на пациентите до иновативни лечения, докато противниците й акцентират върху липсата на ефективен контрол върху разходите и цялостното бюджетно въздействие след това.&lt;/p&gt; &lt;p&gt;Оценката на лекарствата сираци в Германия се характеризира с друга особеност, характерна само за тази юрисдикция. Влезлият в сила през 2011 г. Закон за реформа на пазара на лекарствени продукти освобождава лекарствените терапии с орфанно обозначение от първоначална пълна оценка на здравните ползи. Вместо това, разрешението за пазарна употреба по централизираната процедура на Европейската лекарствена агенция служи като доказателство за наличие на добавени здравни ползи и съответно лекарствата сираци подлежат на съкратена процедура за ускорен достъп. Пълна оценка на тези здравни технологии е задължителна само когато определен лекарствен продукт надвиши 50 милиона евро обем на годишните продажби. В този случай вече, Институтът за качество и ефикасност в здравеопазването следва да извърши пълна оценка на здравните ползи, а Федералният съвместен комитет може да преразгледа решението си за достъп в светлината на представените доказателства. Десет години по-късно е време за равносметка.&lt;/p&#38;gt;},
  doi          = {10.36865/2021.v12i4.148},
  url          = {https://journal.raredis.org/index.php/RBLS/article/view/148},
}

@Article{iskrov_reglament_2020,
  author       = {Искров, Георги and Стефанов, Румен},
  journal      = {Редки болести и лекарства сираци},
  title        = {Регламент (ЕО) № 141/2000 за лекарствата сираци – 20 години по-късно},
  year         = {2020},
  month        = {Oct.},
  number       = {3},
  pages        = {3-4},
  volume       = {11},
  abstractnote = {&lt;p&gt;Тази година отбелязваме 20 години от влизане в сила на Регламент (ЕО) № 141/2000 на Европейския парламент и на Съвета от 16 декември 1999 г. за лекарствата сираци. Този нормативен акт определя критерии за обозначаването на определени лекарствени продукти като лекарства сираци за превенция, диагностика и лечение на редки състояния, както и осигурява стимули за тяхното проучване, разработване и предлагане на пазара. Въпреки че редките болести фигурират в някои по-ранни документи на европейското законодателство, този регламент е първият, който специално и ексклузивно засяга проблемите на хората с редки болести и техните семейства в Европа.&lt;/p&gt; &lt;p&gt;Двадесет години по-късно е време за равносметка. В този контекст, Европейската комисия проведе серия от обществени допитвания с различни заинтересовани страни, последвани от проучване на ефекта и резултатите от Регламент (ЕО) № 141/2000. Поводите за задоволство са много, но и идентифицираните проблеми не са никак малко. По най-важния въпрос обаче – адекватен достъп на пациентите с редки болести до терапия с лекарства сираци – успехът е частичен. Да, броят на лекарствата сираци, получили разрешение за пазарна употреба в ЕС, е значителен. Но в същото време се констатират огромни неравенства при достъпа до тях по страни членки. Съществена част от тези терапии остават недостъпни за пациентите от Източна Европа.&lt;/p&#38;gt;},
  doi          = {10.36865/2020.v11i3.119},
  file         = {:iskrov_reglament_2020 - Регламент (ЕО) № 141_2000 За Лекарствата Сираци – 20 Години По Късно.pdf:PDF},
  url          = {https://journal.raredis.org/index.php/RBLS/article/view/119},
}

@Article{Heus2021,
  author         = {Heus, Eline and Zwan, Jan Maarten and Husson, Olga and Frissen, Anne‐Roos and Herpen, Carla M. L. and Merkx, Matthias A. W. and Duijts, Saskia F. A.},
  journal        = {European Journal of Cancer Care},
  title          = {Unmet supportive care needs of patients with rare cancer: A systematic review},
  year           = {2021},
  issn           = {0961-5423, 1365-2354},
  month          = {aug},
  number         = {6},
  volume         = {30},
  date           = {2021-11},
  doi            = {10.1111/ecc.13502},
  journaltitle   = {European Journal of Cancer Care},
  langid         = {english},
  publisher      = {Wiley},
  qualityassured = {qualityAssured},
  shortjournal   = {Eur J Cancer Care},
  shorttitle     = {Unmet supportive care needs of patients with rare cancer},
  url            = {https://onlinelibrary.wiley.com/doi/10.1111/ecc.13502},
  urldate        = {2022-05-17},
}

@Article{Limon2014,
  author    = {Janusz Limon and Markku Miettinen and Jerzy Lasota},
  journal   = {The International Journal of Biochemistry {\&}amp$\mathsemicolon$ Cell Biology},
  title     = {Rare cancers},
  year      = {2014},
  month     = {aug},
  pages     = {461},
  volume    = {53},
  doi       = {10.1016/j.biocel.2014.06.001},
  publisher = {Elsevier {BV}},
}

@Article{Marques2021,
  author    = {Carina Marques and Charlotte Roberts and Vitor M.J. Matos and Jane E. Buikstra},
  journal   = {International Journal of Paleopathology},
  title     = {Cancers as rare diseases: Terminological, theoretical, and methodological biases},
  year      = {2021},
  month     = {mar},
  pages     = {111--122},
  volume    = {32},
  doi       = {10.1016/j.ijpp.2020.12.005},
  publisher = {Elsevier {BV}},
}

@Article{Kasper2020,
  author    = {Bernd Kasper},
  journal   = {Cancer},
  title     = {The challenge of drug approval in rare cancers},
  year      = {2020},
  month     = {nov},
  number    = {6},
  pages     = {837--839},
  volume    = {127},
  doi       = {10.1002/cncr.33314},
  publisher = {Wiley},
}

@Article{DeSantis2017,
  author         = {{DeSantis}, Carol E. and Kramer, Joan L. and Jemal, Ahmedin},
  journal        = {{CA}: A Cancer Journal for Clinicians},
  title          = {The burden of rare cancers in the United States: The Burden of Rare Cancers in the United States},
  year           = {2017},
  issn           = {00079235},
  month          = {may},
  number         = {4},
  pages          = {261--272},
  volume         = {67},
  date           = {2017-07-08},
  doi            = {10.3322/caac.21400},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\R9T5S86E\\DeSantis и др. - 2017 - The burden of rare cancers in the United States T.pdf:application/pdf},
  journaltitle   = {{CA}: A Cancer Journal for Clinicians},
  langid         = {english},
  publisher      = {Wiley},
  qualityassured = {qualityAssured},
  shortjournal   = {{CA}: A Cancer Journal for Clinicians},
  shorttitle     = {The burden of rare cancers in the United States},
  url            = {http://doi.wiley.com/10.3322/caac.21400},
  urldate        = {2022-05-17},
}

@Article{Finkelstein2019,
  author    = {Dianne M. Finkelstein and Nora K. Horick and Ritesh Ramchandani and Kristina L. Boyd and Huma Q. Rana and Brittany L. Bychkovsky},
  journal   = {{BMC} Cancer},
  title     = {Are rare cancer survivors at elevated risk of subsequent new cancers?},
  year      = {2019},
  month     = {feb},
  number    = {1},
  volume    = {19},
  doi       = {10.1186/s12885-019-5358-1},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{MathoulinPelissier2019,
  author         = {Mathoulin-Pélissier, S. and Pritchard-Jones, K.},
  journal        = {European Journal of Surgical Oncology},
  title          = {Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation},
  year           = {2019},
  issn           = {07487983},
  month          = {jan},
  number         = {1},
  pages          = {22--30},
  volume         = {45},
  date           = {2019-01},
  doi            = {10.1016/j.ejso.2018.02.015},
  file           = {Submitted Version:C\:\\Users\\Kostadin\\Zotero\\storage\\4EIJ9SI6\\Mathoulin-Pélissier и Pritchard-Jones - 2019 - Evidence-based data and rare cancers The need for.pdf:application/pdf},
  journaltitle   = {European Journal of Surgical Oncology},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  shortjournal   = {European Journal of Surgical Oncology},
  shorttitle     = {Evidence-based data and rare cancers},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0748798318306784},
  urldate        = {2022-05-17},
}

@Article{Fair2020,
  author    = {Douglas Fair and Samara L. Potter and Rajkumar Venkatramani},
  journal   = {Current Opinion in Pediatrics},
  title     = {Challenges and solutions to the study of rare childhood tumors},
  year      = {2020},
  month     = {feb},
  number    = {1},
  pages     = {7--12},
  volume    = {32},
  doi       = {10.1097/mop.0000000000000857},
  file      = {:Fair2020 - Challenges and Solutions to the Study of Rare Childhood Tumors.pdf:PDF},
  publisher = {Ovid Technologies (Wolters Kluwer Health)},
}

@Article{Pappo2015,
  author         = {Pappo, Alberto S. and Furman, Wayne L. and Schultz, Kris A. and Ferrari, Andrea and Helman, Lee and Krailo, Mark D.},
  journal        = {Journal of Clinical Oncology},
  title          = {Rare Tumors in Children: Progress Through Collaboration},
  year           = {2015},
  issn           = {0732-183X, 1527-7755},
  month          = {sep},
  number         = {27},
  pages          = {3047--3054},
  volume         = {33},
  abstract       = {Rare pediatric tumors account for approximately 10\% of all childhood cancers, which in themselves are a rare entity. The diverse histologies and clinical behaviors of rare pediatric tumors pose challenges to the investigation of their biologic and clinical features. National and international cooperative groups such as the Rare Tumor Committee of the Children's Oncology Group, Rare Tumors in Pediatric Age Project, and European Cooperative Study Group for Pediatric Rare Tumors have developed several initiatives to advance knowledge about rare pediatric cancers. However, these programs have been only partially effective, necessitating the development of alternative mechanisms to study these challenging diseases. In this article, we review the current national and international collaborative strategies to study rare pediatric cancers and alternative methods under exploration to enhance those efforts, such as independent registries and disease-specific, National Cancer Institute–sponsored clinics.},
  date           = {2015-09-20},
  doi            = {10.1200/JCO.2014.59.3632},
  journaltitle   = {Journal of Clinical Oncology},
  langid         = {english},
  publisher      = {American Society of Clinical Oncology ({ASCO})},
  qualityassured = {qualityAssured},
  shortjournal   = {{JCO}},
  shorttitle     = {Rare Tumors in Children},
  url            = {https://ascopubs.org/doi/10.1200/JCO.2014.59.3632},
  urldate        = {2022-05-17},
}

@Article{Heus2022,
  author         = {de Heus, Eline and Duijts, Saskia F.A. and van der Zwan, Jan Maarten and Kapiteijn, Ellen and Nieveen van Dijkum, Els J.M. and van Herpen, Carla M.L. and Merkx, Matthias A.W.},
  journal        = {European Journal of Cancer},
  title          = {The gap between rare and common cancers still exists: Results from a population-based study in the Netherlands},
  year           = {2022},
  issn           = {09598049},
  month          = {may},
  pages          = {103--111},
  volume         = {167},
  date           = {2022-05},
  doi            = {10.1016/j.ejca.2022.03.001},
  journaltitle   = {European Journal of Cancer},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  ranking        = {rank5},
  readstatus     = {read},
  shortjournal   = {European Journal of Cancer},
  shorttitle     = {The gap between rare and common cancers still exists},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0959804922001319},
  urldate        = {2022-05-17},
}

@Article{James2015,
  author    = {Benjamin C. James and Briseis Aschebrook-Kilfoy and Nicole Cipriani and Edwin L. Kaplan and Peter Angelos and Raymon H. Grogan},
  journal   = {Annals of Surgical Oncology},
  title     = {The Incidence and Survival of Rare Cancers of the Thyroid, Parathyroid, Adrenal, and Pancreas},
  year      = {2015},
  month     = {oct},
  number    = {2},
  pages     = {424--433},
  volume    = {23},
  doi       = {10.1245/s10434-015-4901-9},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Pillai2017,
  author    = {RaveendranK Pillai and K Jayasree},
  journal   = {Indian Journal of Medical Research},
  title     = {Rare cancers: Challenges and issues},
  year      = {2017},
  number    = {1},
  pages     = {17},
  volume    = {145},
  doi       = {10.4103/ijmr.ijmr_915_14},
  publisher = {Medknow},
}

@InCollection{Kanitakis2009,
  author         = {Jean Kanitakis},
  booktitle      = {Skin Cancer after Organ Transplantation},
  publisher      = {Springer {US}},
  title          = {Rare Skin Cancers},
  year           = {2009},
  pages          = {323--328},
  doi            = {10.1007/978-0-387-78574-5_26},
  qualityassured = {qualityAssured},
  relevance      = {relevant},
}

@Article{Acharya2005,
  author    = {Sheetal Acharya and Martee L Hensley and Anthony C Montag and Gini F Fleming},
  journal   = {The Lancet Oncology},
  title     = {Rare uterine cancers},
  year      = {2005},
  month     = {dec},
  number    = {12},
  pages     = {961--971},
  volume    = {6},
  doi       = {10.1016/s1470-2045(05)70463-0},
  publisher = {Elsevier {BV}},
}

@Article{Gatta2006,
  author     = {Gemma Gatta and Laura Ciccolallo and Ian Kunkler and Riccardo Capocaccia and Franco Berrino and Michel P Coleman and Roberta De Angelis and Jean Faivre and Jean Michel Lutz and Carmen Martinez and Torgil Möller and Risto Sankila},
  journal    = {The Lancet Oncology},
  title      = {Survival from rare cancer in adults: a population-based study},
  year       = {2006},
  month      = {feb},
  number     = {2},
  pages      = {132--140},
  volume     = {7},
  doi        = {10.1016/s1470-2045(05)70471-x},
  publisher  = {Elsevier {BV}},
  readstatus = {read},
}

@Article{Visser2012,
  author    = {O. Visser and J. Adolfsson and S. Rossi and J. Verne and G. Gatta and M. Maffezzini and K.N. Franks},
  journal   = {European Journal of Cancer},
  title     = {Incidence and survival of rare urogenital cancers in Europe},
  year      = {2012},
  month     = {mar},
  number    = {4},
  pages     = {456--464},
  volume    = {48},
  doi       = {10.1016/j.ejca.2011.10.031},
  publisher = {Elsevier {BV}},
}

@Article{Stiller2013,
  author    = {C.A. Stiller and A. Trama and D. Serraino and S. Rossi and C. Navarro and M.D. Chirlaque and P.G. Casali},
  journal   = {European Journal of Cancer},
  title     = {Descriptive epidemiology of sarcomas in Europe: Report from the {RARECARE} project},
  year      = {2013},
  month     = {feb},
  number    = {3},
  pages     = {684--695},
  volume    = {49},
  doi       = {10.1016/j.ejca.2012.09.011},
  publisher = {Elsevier {BV}},
}

@Article{Minicozzi2017,
  author    = {Pamela Minicozzi and Kaire Innos and Maria-Jos{\'{e}} S{\'{a}}nchez and Annalisa Trama and Paul M. Walsh and Rafael Marcos-Gragera and Nadya Dimitrova and Laura Botta and Otto Visser and Silvia Rossi and Andrea Tavilla and Milena Sant and M. Hackl and N. Zielonke and E. Van Eycken and K. Henau and Z. Valerianova and N. Dimitrova and M. Sekerija and L. Du{\v{s}}ek and M. Zvolsk{\'{y}} and M. Mägi and T. Aareleid and N. Malila and K. Seppä and A.M. Bouvier and J. Faivre and N. Bossard and Z. Uhry and M. Colonna and R. Stabenow and S. Luttmann and A. Eberle and H. Brenner and A. Nennecke and J. Engel and G. Schubert-Fritschle and J. Heidrich and B. Holleczek and A. Katalinic and K. Clough-Gorr and G. Mazzoleni and A. Bulatko and C. Buzzoni and A. Giacomin and S. Ferretti and A. Barchielli and A. Caldarella and G. Gatta and M. Sant and H. Amash and C. Amati and P. Baili and F. Berrino and S. Bonfarnuzzo and L. Botta and R. Capocaccia and F. Di Salvo and R. Foschi and C. Margutti and E. Meneghini and P. Minicozzi and A. Trama and D. Serraino and L. Dal Maso and R. De Angelis and M. Caldora and E. Carrani and S. Francisci and A. Knijn and S. Mallone and D. Pierannunzio and P. Roazzi and S. Rossi and M. Santaquilani and A. Tavilla and F. Pannozzo and M. Natali and R.A. Filiberti and E. Marani and M. Autelitano and G. Spagnoli and C. Cirilli and M. Fusco and M.F. Vitale and A. Traina and R. Staiti and F. Vitale and R. Cusimano and M. Michiara and R. Tumino and F. Falcini and A.L. Caiazzo and S. Maspero and A.C. Fanetti and R. Zanetti and S. Rosso and M. Rugge and S. Tognazzo and S. Pildava and G. Smailyte and T.B. Johannesen and J. Rachtan and S. G{\'{o}}{\'{z}}d{\'{z}} and R. M{\k{e}}{\.{z}}yk and J. B{\l}aszczyk and K. K{\k{e}}pska and M. Bielska-Lasota and G. Forjaz de Lacerda and M.J. Bento and L. Antunes and A. Miranda and A. Mayer-da-Silva and C. Safaei Diba and M. Primic-Zakelj and E. Almar and A. Mateos and A. Lopez de Munain and N. Larra{\~{n}}aga and A. Torrella-Ramos and J.M. D{\'{\i}}az Garc{\'{\i}}a and R. Jimenez-Chillaron and R. Marcos-Gragera and L. Vilardell and C. Moreno-Iribas and E. Ardanaz and M. Lambe and M. Mousavi and C. Bouchardy and M. Usel and S.M. Ess and H. Frick and M. Lorez and S.M. Ess and C. Herrmann and A. Bordoni and A. Spitale and I. Konzelmann and O. Visser and R. Damhuis and R. Otter and M. Coleman and C. Allemani and B. Rachet and J. Rashbass and J. Broggio and J. Verne and A. Gavin and D. Fitzpatrick and D.W. Huws and C. White},
  journal   = {European Journal of Cancer},
  title     = {Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A~{EUROCARE}-5 study},
  year      = {2017},
  month     = {oct},
  pages     = {335--353},
  volume    = {84},
  doi       = {10.1016/j.ejca.2017.07.015},
  publisher = {Elsevier {BV}},
}

@Article{berrino2009comparative,
  author    = {Berrino, Franco and Verdecchia, Arduino and Lutz, Jean Michel and Lombardo, Claudio and Micheli, Andrea and Capocaccia, Riccardo},
  journal   = {European Journal of Cancer},
  title     = {Comparative cancer survival information in Europe},
  year      = {2009},
  number    = {6},
  pages     = {901--908},
  volume    = {45},
  publisher = {Elsevier},
}

@Article{capocaccia2002measuring,
  author    = {Capocaccia, R and Colonna, M and Corazziari, I and De Angelis, R and Francisci, S and Micheli, A and Mugno, E},
  journal   = {Annals of Oncology},
  title     = {Measuring cancer prevalence in Europe: the EUROPREVAL project},
  year      = {2002},
  number    = {6},
  pages     = {831--839},
  volume    = {13},
  publisher = {Elsevier},
}

@Article{de2009eurocare,
  author    = {De Angelis, Roberta and Francisci, Silvia and Baili, Paolo and Marchesi, Francesca and Roazzi, Paolo and Belot, Aur{\'e}lien and Crocetti, Emanuele and Pury, Pierre and Knijn, Arnold and Coleman, Michel and others},
  journal   = {European Journal of Cancer},
  title     = {The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis},
  year      = {2009},
  number    = {6},
  pages     = {909--930},
  volume    = {45},
  publisher = {Elsevier},
}

@Article{Casali2022,
  author    = {Paolo G. Casali and Salvatore Provenzano and Annalisa Trama},
  journal   = {Recenti Progressi in Medicina},
  title     = {Il problema dei tumori rari},
  year      = {2022},
  doi       = {10.1701/3850.38337},
  publisher = {Il Pensiero Scientifico Editore},
}

@InProceedings{Zwan2014InformationNO,
  author = {Jan Maarten van der Zwan and Annalisa Trama and Riccardo Capocaccia and Gemma Gatta and Sabine Siesling},
  title  = {Information network on Rare Cancers},
  year   = {2014},
}

@Article{PritchardJones2006,
  author    = {K. Pritchard-Jones and P. Kaatsch and E. Steliarova-Foucher and C.A. Stiller and J.W.W. Coebergh},
  journal   = {European Journal of Cancer},
  title     = {Cancer in children and adolescents in Europe: Developments over 20 years and future challenges},
  year      = {2006},
  month     = {sep},
  number    = {13},
  pages     = {2183--2190},
  volume    = {42},
  doi       = {10.1016/j.ejca.2006.06.006},
  publisher = {Elsevier {BV}},
}

@Article{Griggs2009,
  author     = {Robert C. Griggs and Mark Batshaw and Mary Dunkle and Rashmi Gopal-Srivastava and Edward Kaye and Jeffrey Krischer and Tan Nguyen and Kathleen Paulus and Peter A. Merkel},
  journal    = {Molecular Genetics and Metabolism},
  title      = {Clinical research for rare disease: Opportunities, challenges, and solutions},
  year       = {2009},
  month      = {jan},
  number     = {1},
  pages      = {20--26},
  volume     = {96},
  doi        = {10.1016/j.ymgme.2008.10.003},
  publisher  = {Elsevier {BV}},
  readstatus = {read},
}

@Article{Sledge2005,
  author     = {George W. Sledge},
  journal    = {Journal of Clinical Oncology},
  title      = {What Is Targeted Therapy?},
  year       = {2005},
  month      = {mar},
  number     = {8},
  pages      = {1614--1615},
  volume     = {23},
  doi        = {10.1200/jco.2005.01.016},
  publisher  = {American Society of Clinical Oncology ({ASCO})},
  ranking    = {rank4},
  readstatus = {read},
}

@Article{Braiteh2007,
  author     = {Fadi Braiteh and Razelle Kurzrock},
  journal    = {Molecular Cancer Therapeutics},
  title      = {Uncommon tumors and exceptional therapies: paradox or paradigm?},
  year       = {2007},
  month      = {apr},
  number     = {4},
  pages      = {1175--1179},
  volume     = {6},
  doi        = {10.1158/1535-7163.mct-06-0674},
  publisher  = {American Association for Cancer Research ({AACR})},
  readstatus = {read},
}

@Article{Choi2010,
  author    = {Young Lim Choi and Manabu Soda and Yoshihiro Yamashita and Toshihide Ueno and Junpei Takashima and Takahiro Nakajima and Yasushi Yatabe and Kengo Takeuchi and Toru Hamada and Hidenori Haruta and Yuichi Ishikawa and Hideki Kimura and Tetsuya Mitsudomi and Yoshiro Tanio and Hiroyuki Mano},
  journal   = {New England Journal of Medicine},
  title     = {{EML}4-{ALK} Mutations in Lung Cancer That Confer Resistance to {ALK} Inhibitors},
  year      = {2010},
  month     = {oct},
  number    = {18},
  pages     = {1734--1739},
  volume    = {363},
  doi       = {10.1056/nejmoa1007478},
  publisher = {Massachusetts Medical Society},
}

@Article{Thatcher2005,
  author    = {Nick Thatcher and Alex Chang and Purvish Parikh and Jos{\'{e}} Rodrigues Pereira and Tudor Ciuleanu and Joachim von Pawel and Sumitra Thongprasert and Eng Huat Tan and Kristine Pemberton and Venice Archer and Kevin Carroll},
  journal   = {The Lancet},
  title     = {Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)},
  year      = {2005},
  month     = {oct},
  number    = {9496},
  pages     = {1527--1537},
  volume    = {366},
  doi       = {10.1016/s0140-6736(05)67625-8},
  publisher = {Elsevier {BV}},
}

@Article{balcerska2004rare,
  author  = {Balcerska, Anna and Godzi{\'n}ski, Jan and Bie{\'n}, Ewa and Stachowicz-Stencel, Teresa and Sulka, Wojciech and Rapa{\l}a, Ma{\l}gorzata and Izycka-Swieszewska, Ewa and Perek-Polnik, Marta and Drogosiewicz, Monika and Perek, Danuta and others},
  journal = {Przeglad lekarski},
  title   = {Rare tumours--are they really rare in the Polish children population?},
  year    = {2004},
  pages   = {57--61},
  volume  = {61},
}

@Article{Bien2011,
  author    = {Ewa Bien and Jan Godzinski and Patrizia Dall'Igna and Anne-Sophie Defachelles and Teresa Stachowicz-Stencel and Daniel Orbach and Gianni Bisogno and Giovanni Cecchetto and Steven Warmann and Verena Ellerkamp and Bernadette Brennan and Anna Balcerska and Malgorzata Rapala and Ines Brecht and Dominik Schneider and Andrea Ferrari},
  journal   = {European Journal of Cancer},
  title     = {Pancreatoblastoma: A report from the European cooperative study group for paediatric rare tumours ({EXPeRT})},
  year      = {2011},
  month     = {oct},
  number    = {15},
  pages     = {2347--2352},
  volume    = {47},
  doi       = {10.1016/j.ejca.2011.05.022},
  publisher = {Elsevier {BV}},
}

@Article{brennan2010pediatric,
  author  = {Brennan, Bernadette},
  journal = {Pediatric blood \& cancer},
  title   = {Pediatric pancreatic tumors: the orphan looking for a home},
  year    = {2010},
  number  = {54},
  pages   = {659--660},
  volume  = {5},
}

@Article{Ferrari2007,
  author     = {Andrea Ferrari and Gianni Bisogno and Gian Luca De Salvo and Paolo Indolfi and Giorgio Perilongo and Giovanni Cecchetto},
  journal    = {European Journal of Cancer},
  title      = {The challenge of very rare tumours in childhood: The Italian {TREP} project},
  year       = {2007},
  month      = {mar},
  number     = {4},
  pages      = {654--659},
  volume     = {43},
  doi        = {10.1016/j.ejca.2006.08.028},
  publisher  = {Elsevier {BV}},
  readstatus = {read},
}

@Article{Lacour2010,
  author    = {Brigitte Lacour and Aur{\'{e}}lie Guyot-Goubin and Sandra Guissou and St{\'{e}}phanie Bellec and Emmanuel D{\'{e}}sandes and Jacqueline Clavel},
  journal   = {European Journal of Cancer Prevention},
  title     = {Incidence of childhood cancer in France: National Children Cancer Registries, 2000{\textendash}2004},
  year      = {2010},
  month     = {may},
  number    = {3},
  pages     = {173--181},
  volume    = {19},
  doi       = {10.1097/cej.0b013e32833876c0},
  publisher = {Ovid Technologies (Wolters Kluwer Health)},
}

@Article{Merks2011,
  author    = {Johannes H. M. Merks and Ines B. Brecht},
  title     = {Genetic Predisposition and Genetic Susceptibility},
  year      = {2011},
  month     = {oct},
  pages     = {69--94},
  booktitle = {Rare Tumors In Children and Adolescents},
  doi       = {10.1007/978-3-642-04197-6_6},
  publisher = {Springer Berlin Heidelberg},
}

@Article{Reguerre2010,
  author    = {Y. R{\'{e}}guerre and B. Lacour and N. Andr{\'{e}} and L. Claude and F. Hameury and F. Lavrand and N. Kalfa and M. Peuchmaur and D. Orbach},
  journal   = {Bulletin du Cancer},
  title     = {Tumeurs rares en p{\'{e}}diatrie : particularit{\'{e}}s {\'{e}}pid{\'{e}}miologiques et organisation de leur prise en charge dans le cadre de la Soci{\'{e}}t{\'{e}} fran{\c{c}}aise des cancers et des leuc{\'{e}}mies de l{\textquotesingle}enfant et de l{\textquotesingle}adolescent ({SFCE})},
  year      = {2010},
  month     = {sep},
  number    = {9},
  pages     = {1041--1045},
  volume    = {97},
  doi       = {10.1684/bdc.2010.1169},
  publisher = {Elsevier {BV}},
}

@Article{Schneider2010,
  author    = {D. T. Schneider and I. B. Brecht},
  journal   = {Klinische Pädiatrie},
  title     = {Care for Rare Cancers: Improved Care Requires Improved Communication},
  year      = {2010},
  month     = {may},
  number    = {03},
  pages     = {124--126},
  volume    = {222},
  doi       = {10.1055/s-0030-1252028},
  publisher = {Georg Thieme Verlag {KG}},
}

@Article{Trama2012,
  author    = {Annalisa Trama and Sandra Mallone and Stefano Ferretti and Francesca Meduri and Riccardo Capocaccia and Gemma Gatta},
  journal   = {Tumori},
  title     = {The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.},
  year      = {2012},
  pages     = {550-8},
  volume    = {98 5},
  doi       = {10.1700/1190.13194},
  publisher = {Il Pensiero Scientifico Editore},
}

@Article{Castaing2016,
  author    = {Marine Castaing and Francesca Bella and Rosalba Amodio and Sabrina Bizzoco and Tiziana Cassetti and Claudia Cirilli and Rosanna Cusimano and Roberta De Angelis and Mario Fusco and Gemma Gatta and Valerio Gennaro and Adriano Giacomin and Paolo Giorgi Rossi and Lucia Mangone and Salvatore Mannino and Silvia Rossi and Daniela Pierannunzio and Andrea Tavilla and Sandro Tognazzo and Rosario Tumino and Massimo Vicentini and Maria Francesca Vitale},
  journal   = {Epidemiologia & Prevenzione},
  title     = {I tumori in Italia - Rapporto 2015: I tumori rari in Italia},
  year      = {2016},
  issn      = {1120-9763, 2385-1937},
  pages     = {1-120},
  volume    = {40},
  doi       = {10.19191/EP16.1S2.P001.035},
  publisher = {Inferenze scarl},
}

@Article{Reinke2021,
  author    = {Denise K. Reinke},
  journal   = {Current Problems in Cancer},
  title     = {Meaningful engagement of the patient in rare cancer research: sarcoma as an exemplar},
  year      = {2021},
  month     = {aug},
  number    = {4},
  pages     = {100772},
  volume    = {45},
  doi       = {10.1016/j.currproblcancer.2021.100772},
  publisher = {Elsevier {BV}},
}

@Article{Walker2020,
  author         = {Walker, E.V. and Maplethorpe, E. and Davis, F.G.},
  journal        = {Cancer Epidemiology},
  title          = {Rare cancers in Canada, 2006–2016: A population-based surveillance report and comparison of different methods for classifying rare cancers},
  year           = {2020},
  issn           = {18777821},
  month          = {aug},
  pages          = {101721},
  volume         = {67},
  date           = {2020-08},
  doi            = {10.1016/j.canep.2020.101721},
  journaltitle   = {Cancer Epidemiology},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  shortjournal   = {Cancer Epidemiology},
  shorttitle     = {Rare cancers in Canada, 2006–2016},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S1877782120300552},
  urldate        = {2022-05-17},
}

@Article{Casali2020,
  author         = {Casali, Paolo G. and Trama, Annalisa},
  journal        = {{ESMO} Open},
  title          = {Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers ({JARC}) of the European Union ({EU})},
  year           = {2020},
  issn           = {20597029},
  number         = {2},
  pages          = {e000666},
  volume         = {5},
  date           = {2020},
  doi            = {10.1136/esmoopen-2019-000666},
  journaltitle   = {{ESMO} Open},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  shortjournal   = {{ESMO} Open},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S2059702920300648},
  urldate        = {2022-05-17},
}

@Article{Fiorentino2021,
  author    = {Alba Fiorentino and Fabiana Gregucci and Isacco Desideri and Michele Fiore and Lorenza Marino and Angelo Errico and Alessia Di Rito and Paolo Borghetti and Pierfrancesco Franco and Daniela Greto and Vittorio Donato},
  journal   = {Critical Reviews in Oncology/Hematology},
  title     = {Radiation treatment for adult rare cancers: Oldest and newest indication},
  year      = {2021},
  month     = {mar},
  pages     = {103228},
  volume    = {159},
  doi       = {10.1016/j.critrevonc.2021.103228},
  publisher = {Elsevier {BV}},
}

@Article{Angeli2022,
  author    = {Kevin De Angeli and Shang Gao and Ioana Danciu and Eric B. Durbin and Xiao-Cheng Wu and Antoinette Stroup and Jennifer Doherty and Stephen Schwartz and Charles Wiggins and Mark Damesyn and Linda Coyle and Lynne Penberthy and Georgia D. Tourassi and Hong-Jun Yoon},
  journal   = {Journal of Biomedical Informatics},
  title     = {Class imbalance in out-of-distribution datasets: Improving the robustness of the {TextCNN} for the classification of rare cancer types},
  year      = {2022},
  month     = {jan},
  pages     = {103957},
  volume    = {125},
  doi       = {10.1016/j.jbi.2021.103957},
  publisher = {Elsevier {BV}},
}

@Article{Prades2020,
  author    = {Joan Prades and Ariane Weinman and Yann Le Cam and Annalisa Trama and Anna Maria Frezza and Josep M. Borras},
  journal   = {Journal of Cancer Policy},
  title     = {Priorities on rare cancers' policy in National Cancer Control Plans ({NCCPs}): A review conducted within the framework of {EU}-{JARC} Joint-Action},
  year      = {2020},
  month     = {jun},
  pages     = {100222},
  volume    = {24},
  doi       = {10.1016/j.jcpo.2020.100222},
  publisher = {Elsevier {BV}},
}

@Article{RodriguezMartin2018,
  author         = {Rodriguez-Martin, Ana-Maria and Zacharopoulou, Panagiota and Hassan, A. Bassim and Tsiachristas, Apostolos},
  journal        = {Journal of Cancer Policy},
  title          = {Cost-effectiveness of healthcare interventions for rare cancers: Evidence from a systematic literature review and meta-analysis},
  year           = {2018},
  issn           = {22135383},
  month          = {dec},
  pages          = {1--10},
  volume         = {18},
  date           = {2018-12},
  doi            = {10.1016/j.jcpo.2018.08.001},
  file           = {Accepted Version:C\:\\Users\\Kostadin\\Zotero\\storage\\9XNQ8AVQ\\Rodriguez-Martin и др. - 2018 - Cost-effectiveness of healthcare interventions for.pdf:application/pdf},
  journaltitle   = {Journal of Cancer Policy},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  shortjournal   = {Journal of Cancer Policy},
  shorttitle     = {Cost-effectiveness of healthcare interventions for rare cancers},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S2213538318300146},
  urldate        = {2022-05-17},
}

@Article{Satake2022,
  author     = {Tomoyuki Satake and Chigusa Morizane and Ryoko Rikitake and Shintaro Iwata and Hidekazu Hirano and Dai Ogata and Tatsunori Shimoi and Kazuki Sudo and Seiichi Yoshimoto and Naoya Yamazaki and Yoko Katoh and Takahiro Higashi and Akira Kawai},
  journal    = {Annals of Oncology},
  title      = {O12-2 The epidemiology of rare cancers from National Cancer Registry in Japan},
  year       = {2022},
  month      = {jul},
  pages      = {S473--S474},
  volume     = {33},
  doi        = {10.1016/j.annonc.2022.05.038},
  publisher  = {Elsevier {BV}},
  readstatus = {skimmed},
}

@Article{Okuma2022,
  author     = {Hitomi Okuma},
  journal    = {Annals of Oncology},
  title      = {{SY}24-1 {MASTER} {KEY} Project: A platform study for rare cancers in Japan and Asia},
  year       = {2022},
  month      = {jul},
  pages      = {S448},
  volume     = {33},
  doi        = {10.1016/j.annonc.2022.05.486},
  publisher  = {Elsevier {BV}},
  readstatus = {read},
}

@Article{Louveau2020,
  author    = {Baptiste Louveau and Fan{\'{e}}lie Jouenne and Florentia Kaguelidou and Alexandra Landras and Lauriane Goldwirt and Samia Mourah},
  journal   = {Therapies},
  title     = {The key role of oncopharmacology in therapeutic management, from common to rare cancers: A literature review},
  year      = {2020},
  month     = {apr},
  number    = {2},
  pages     = {183--193},
  volume    = {75},
  doi       = {10.1016/j.therap.2020.02.010},
  publisher = {Elsevier {BV}},
}

@Article{Koo2020,
  author    = {Minjoung Monica Koo and Ruth Swann and Sean McPhail and Gary A. Abel and Cristina Renzi and Greg P. Rubin and Georgios Lyratzopoulos},
  journal   = {Cancer Epidemiology},
  title     = {The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: A cross-sectional study using primary care data},
  year      = {2020},
  month     = {dec},
  pages     = {101845},
  volume    = {69},
  doi       = {10.1016/j.canep.2020.101845},
  publisher = {Elsevier {BV}},
}

@Article{Sharifnia2017,
  author    = {Tanaz Sharifnia and Andrew L. Hong and Corrie A. Painter and Jesse S. Boehm},
  journal   = {Cell Chemical Biology},
  title     = {Emerging Opportunities for Target Discovery in Rare Cancers},
  year      = {2017},
  month     = {sep},
  number    = {9},
  pages     = {1075--1091},
  volume    = {24},
  doi       = {10.1016/j.chembiol.2017.08.002},
  publisher = {Elsevier {BV}},
  relevance = {relevant},
}

@Article{Gonzato2017,
  author    = {Ornella Gonzato},
  journal   = {Journal of Cancer Policy},
  title     = {The new risk-sharing paradigm in rare cancers: Patient perspective},
  year      = {2017},
  month     = {jun},
  pages     = {36--42},
  volume    = {12},
  doi       = {10.1016/j.jcpo.2017.03.007},
  publisher = {Elsevier {BV}},
}

@Article{Chawla2022,
  author     = {A Chawla and H Patel and R Folorunso},
  journal    = {Value in Health},
  title      = {{HTA}45 Care for Rare: Market Access Evidentiary Requirements for Rare Cancers},
  year       = {2022},
  month      = {jul},
  number     = {7},
  pages      = {S512},
  volume     = {25},
  doi        = {10.1016/j.jval.2022.04.1177},
  publisher  = {Elsevier {BV}},
  ranking    = {rank2},
  readstatus = {read},
}

@Article{Schwarze2020,
  author    = {Katharina Schwarze and James Buchanan and Jilles M. Fermont and Helene Dreau and Mark W. Tilley and John M. Taylor and Pavlos Antoniou and Samantha J.L. Knight and Carme Camps and Melissa M. Pentony and Erika M. Kvikstad and Steve Harris and Niko Popitsch and Alistair T. Pagnamenta and Anna Schuh and Jenny C. Taylor and Sarah Wordsworth},
  journal   = {Genetics in Medicine},
  title     = {The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom},
  year      = {2020},
  month     = {jan},
  number    = {1},
  pages     = {85--94},
  volume    = {22},
  doi       = {10.1038/s41436-019-0618-7},
  publisher = {Elsevier {BV}},
}

@Article{Eslick2012,
  author    = {Guy D. Eslick},
  journal   = {Hematology/Oncology Clinics of North America},
  title     = {What is a Rare Cancer?},
  year      = {2012},
  month     = {dec},
  number    = {6},
  pages     = {1137--1141},
  volume    = {26},
  doi       = {10.1016/j.hoc.2012.09.002},
  publisher = {Elsevier {BV}},
}

@Article{Katoh2019,
  author    = {Yoko Katoh and Akira Kawai and Taro Shibata and Yasushi Goto and Tatsuya Suzuki and Shintaro Iwata and Kan Yonemori and Wataru Munakata and Eriko Satomi and Akihiko Yoshida and Takuro Sakurai and Tomoko Takayama and Takahiro Higashi and Tosirou Nishida},
  journal   = {Annals of Oncology},
  title     = {Rare Cancer Center - All Activities for Rare Cancer Patients! -},
  year      = {2019},
  month     = {oct},
  pages     = {vi51},
  volume    = {30},
  doi       = {10.1093/annonc/mdz341.002},
  publisher = {Elsevier {BV}},
}

@Article{Gu2019,
  author    = {Hongfei Gu},
  journal   = {Annals of Oncology},
  title     = {Rare Cancers China Programs starting up},
  year      = {2019},
  month     = {oct},
  pages     = {vi8},
  volume    = {30},
  doi       = {10.1093/annonc/mdz305.002},
  publisher = {Elsevier {BV}},
}

@Article{Bogaerts2015,
  author         = {Bogaerts, Jan and Sydes, Matthew R. and Keat, Nicola and {McConnell}, Andrea and Benson, Al and Ho, Alan and Roth, Arnaud and Fortpied, Catherine and Eng, Cathy and Peckitt, Clare and Coens, Corneel and Pettaway, Curtis and Arnold, Dirk and Hall, Emma and Marshall, Ernie and Sclafani, Francesco and Hatcher, Helen and Earl, Helena and Ray-Coquard, Isabelle and Paul, James and Blay, Jean-Yves and Whelan, Jeremy and Panageas, Kathy and Wheatley, Keith and Harrington, Kevin and Licitra, Lisa and Billingham, Lucinda and Hensley, Martee and {McCabe}, Martin and Patel, Poulam M. and Carvajal, Richard and Wilson, Richard and Glynne-Jones, Rob and {McWilliams}, Rob and Leyvraz, Serge and Rao, Sheela and Nicholson, Steve and Filiaci, Virginia and Negrouk, Anastassia and Lacombe, Denis and Dupont, Elisabeth and Pauporté, Iris and Welch, John J. and Law, Kate and Trimble, Ted and Seymour, Matthew},
  journal        = {European Journal of Cancer},
  title          = {Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative},
  year           = {2015},
  issn           = {09598049},
  month          = {feb},
  number         = {3},
  pages          = {271--281},
  volume         = {51},
  date           = {2015-02},
  doi            = {10.1016/j.ejca.2014.10.027},
  file           = {Full Text:C\:\\Users\\Kostadin\\Zotero\\storage\\LQPH7D5S\\Bogaerts и др. - 2015 - Clinical trial designs for rare diseases Studies .pdf:application/pdf},
  journaltitle   = {European Journal of Cancer},
  langid         = {english},
  publisher      = {Elsevier {BV}},
  qualityassured = {qualityAssured},
  shortjournal   = {European Journal of Cancer},
  shorttitle     = {Clinical trial designs for rare diseases},
  url            = {https://linkinghub.elsevier.com/retrieve/pii/S0959804914010636},
  urldate        = {2022-05-17},
}

@Article{Sandler2021,
  author    = {Abby Sandler and Karlyne Reilly and Brigitte Widemann},
  journal   = {Current Problems in Cancer},
  title     = {Editorial: Special issue on rare cancers},
  year      = {2021},
  month     = {aug},
  number    = {4},
  pages     = {100774},
  volume    = {45},
  doi       = {10.1016/j.currproblcancer.2021.100774},
  publisher = {Elsevier {BV}},
}

@Article{Sandrucci2019a,
  author    = {S. Sandrucci and P. Naredi and S. Bonvalot},
  journal   = {European Journal of Surgical Oncology},
  title     = {Centers of excellence or excellence networks: The surgical challenge and quality issues in rare cancers},
  year      = {2019},
  month     = {jan},
  number    = {1},
  pages     = {19--21},
  volume    = {45},
  doi       = {10.1016/j.ejso.2017.12.012},
  publisher = {Elsevier {BV}},
}

@Article{Missaoui2018,
  author    = {Nabiha Missaoui and Sarra Mestiri and Ahlem Bdioui and Thouraya Zahmoul and Hajer Hamchi and Moncef Mokni and Sihem Hmissa},
  journal   = {Pathology - Research and Practice},
  title     = {{HPV} infection and p16 {INK}4A and {TP}53 expression in rare cancers of the uterine cervix},
  year      = {2018},
  month     = {apr},
  number    = {4},
  pages     = {498--506},
  volume    = {214},
  doi       = {10.1016/j.prp.2018.03.004},
  publisher = {Elsevier {BV}},
}

@Article{Blay2021,
  author    = {J.-Y. Blay and P. Casali and C. Bouvier and C. Dehais and I. Galloway and J. Gietema and J. Hal{\'{a}}mkov{\'{a}} and N. Hindi and A. Idbaih and E. Kinloch and H.-J. Klümpen and T. Kolarova and K. Kopeckova and J. Lovey and M. Magalhaes and K. Oselin and S. Piperno-Neumann and A. Ravnsbaek and M. Rogasik and A. Safwat and S. Scheipl and M. Seckl and J. Taylor and M. Temnyk and A. Trama and M. Urbonas and M. Wartenberg and A. Weinman},
  journal   = {{ESMO} Open},
  title     = {European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the {ERN} {EURACAN}},
  year      = {2021},
  month     = {aug},
  number    = {4},
  pages     = {100174},
  volume    = {6},
  doi       = {10.1016/j.esmoop.2021.100174},
  publisher = {Elsevier {BV}},
}

@Article{Gladdy2021,
  author    = {R.A. Gladdy},
  journal   = {Annals of Oncology},
  title     = {Precision guidelines for soft tissue and visceral sarcomas: the evidence, expert experience and ensuring optimal care for rare cancers, a 2021 update from {ESMO}{\textendash}{EURACAN}{\textendash}{GENTURIS}},
  year      = {2021},
  month     = {nov},
  number    = {11},
  pages     = {1325--1326},
  volume    = {32},
  doi       = {10.1016/j.annonc.2021.08.2155},
  publisher = {Elsevier {BV}},
}

@Article{Vinches2019,
  author    = {M. Vinches and A. Stevovic and I.L. Ray-Coquard and I. Treilleux and P. Meeus and S. Aust and A. Floquet and S. Croce and L. Chalabreysse and N. Girard and J-Y Blay and M. Morfouace},
  journal   = {Annals of Oncology},
  title     = {Arcagen: An {EORTC}-{SPECTA} project to perform a molecular characterization of rare cancers: Results of the retrospective feasibility cohort},
  year      = {2019},
  month     = {nov},
  pages     = {vii24},
  volume    = {30},
  doi       = {10.1093/annonc/mdz413.086},
  publisher = {Elsevier {BV}},
}

@Article{Larsen2019,
  author    = {Francisco Larsen and Mario Terlizzi and Virginia Linacre and Paul Sargos and Francisco Suarez and Youlia Kirova and Paul Van Houtte and Delphine Lerouge and Thomas Zilli and Claudio V. Sole},
  journal   = {International Journal of Radiation Oncology{\ast}Biology{\ast}Physics},
  title     = {Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study},
  year      = {2019},
  month     = {apr},
  number    = {5},
  pages     = {1175--1181},
  volume    = {103},
  doi       = {10.1016/j.ijrobp.2018.12.022},
  publisher = {Elsevier {BV}},
}

@Article{Amaya2019,
  author    = {Yosuke Amaya and Kan Yonemori and Hitomi Sumiyoshi Okuma and Shoko Narita and Akihiro Hirakawa and Natsuko Okita and Tamie Sukigara and Masashi Kanai and Manabu Muto and Kenichi Nakamura and Yasuhiro Fujiwara},
  journal   = {Annals of Oncology},
  title     = {{ROCK} Trial ({NCCH}1709): Nivolumab monotherapy in Rare cancer patients with mismatch repair deficiency biomarker: phase {II}},
  year      = {2019},
  month     = {oct},
  pages     = {vi137},
  volume    = {30},
  doi       = {10.1093/annonc/mdz343.088},
  publisher = {Elsevier {BV}},
}

@Article{Blay2021a,
  author    = {Jean-Yves Blay and Pierre Fenaux and Ruth Ladenstein and Nicoline Hoogerbrugge},
  journal   = {The Lancet},
  title     = {Continue rare cancers collaboration with European Reference Networks after Brexit},
  year      = {2021},
  month     = {feb},
  number    = {10276},
  pages     = {793},
  volume    = {397},
  doi       = {10.1016/s0140-6736(21)00264-6},
  publisher = {Elsevier {BV}},
}

@Article{Atalar2018,
  author    = {Banu Atalar and Mahmut Ozsahin and Jason Call and Aleksandra Napieralska and Serra Kamer and Salvador Villa and Petek Erpolat and Laura Negretti and Yasmin Lassen-Ramshad and Cem Onal and Serap Akyurek and Gamze Ugurluer and Brigitta G. Baumert and Stephanie Servagi-Vernat and Robert C. Miller and Enis Ozyar and Terence T. Sio},
  journal   = {Radiotherapy and Oncology},
  title     = {Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network ({RCN}) experience},
  year      = {2018},
  month     = {apr},
  number    = {1},
  pages     = {96--102},
  volume    = {127},
  doi       = {10.1016/j.radonc.2017.12.028},
  publisher = {Elsevier {BV}},
}

@Article{Sidiropoulos2012,
  author    = {Konstantinos Sidiropoulos and Dimitrios Glotsos and Spiros Kostopoulos and Panagiota Ravazoula and Ioannis Kalatzis and Dionisis Cavouras and John Stonham},
  journal   = {Computers in Biology and Medicine},
  title     = {Real time decision support system for diagnosis of rare cancers, trained in parallel, on a graphics processing unit},
  year      = {2012},
  month     = {apr},
  number    = {4},
  pages     = {376--386},
  volume    = {42},
  doi       = {10.1016/j.compbiomed.2011.12.004},
  publisher = {Elsevier {BV}},
}

@Article{Lu2021,
  author    = {Donna Lu},
  journal   = {New Scientist},
  title     = {Rare cancers jumped from mother to child},
  year      = {2021},
  month     = {jan},
  number    = {3317},
  pages     = {20},
  volume    = {249},
  doi       = {10.1016/s0262-4079(21)00050-6},
  publisher = {Elsevier {BV}},
}

@Article{Gonzato2016,
  author    = {Ornella Gonzato},
  journal   = {Journal of Cancer Policy},
  title     = {Could information improve patient access to new emerging drugs in rare cancer trials?},
  year      = {2016},
  month     = {jun},
  pages     = {38--41},
  volume    = {8},
  doi       = {10.1016/j.jcpo.2016.04.001},
  publisher = {Elsevier {BV}},
}

@Article{Vokinger2020,
  author    = {K.N. Vokinger and P. Daniore and A.S. Kesselheim},
  journal   = {Annals of Oncology},
  title     = {1586MO Pivotal trial endpoints of drugs for rare and non-rare cancers in the {US} and Europe},
  year      = {2020},
  month     = {sep},
  pages     = {S1197},
  volume    = {31},
  doi       = {10.1016/j.annonc.2020.08.2307},
  publisher = {Elsevier {BV}},
}

@Article{Siesling2012,
  author    = {Sabine Siesling and Jan Maarten van der Zwan and Isabel Izarzugaza and Jana Jaal and Tom Treasure and Roberto Foschi and Umberto Ricardi and Harry Groen and Andrea Tavilla and Eva Ardanaz},
  journal   = {European Journal of Cancer},
  title     = {Rare thoracic cancers, including peritoneum mesothelioma},
  year      = {2012},
  month     = {may},
  number    = {7},
  pages     = {949--960},
  volume    = {48},
  doi       = {10.1016/j.ejca.2012.02.047},
  publisher = {Elsevier {BV}},
}

@Article{Gramaca2021,
  author    = {J. Grama{\c{c}}a and D.D. Machado and T. Ponte and I. Pina},
  journal   = {Thrombosis Research},
  title     = {{PO}-102 Bleeding management challenges in rare cancer-associated thrombosis: a case report of inferior vena cava thrombus in a patient with testicular germ cell tumour},
  year      = {2021},
  month     = {apr},
  pages     = {S74--S75},
  volume    = {200},
  doi       = {10.1016/s0049-3848(21)00172-9},
  publisher = {Elsevier {BV}},
}

@Article{Morfouace2020,
  author    = {M. Morfouace and I. Ray-Coquard and N. Girard and A. Stevovic and I. Treilleux and P. Meeus and S. Aust and A. Floquet and S. Croce and M. Seckl and J. Gietema and M. Caplin and C. delaFouchardiere and L. Licitra and H. Kapiteijn and S. Piperno Neumann and A. Idbaih and J.Y. Blay},
  journal   = {European Journal of Cancer},
  title     = {Arcagen: Molecular profiling of rare cancer patients {\textendash} analysis of the pilot study (87 patients)},
  year      = {2020},
  month     = {oct},
  pages     = {S32},
  volume    = {138},
  doi       = {10.1016/s0959-8049(20)31155-2},
  publisher = {Elsevier {BV}},
}

@Article{Longabaugh2017,
  author    = {Michele Longabaugh},
  journal   = {Surgical Oncology Clinics of North America},
  title     = {Patient Perspective and Personal Journey of Treating a {\textquotedblleft}Rare Cancer{\textquotedblright}},
  year      = {2017},
  month     = {jan},
  number    = {1},
  pages     = {1--7},
  volume    = {26},
  doi       = {10.1016/j.soc.2016.07.014},
  publisher = {Elsevier {BV}},
}

@Article{Ashley2015,
  author    = {David Ashley and David Thomas and Lia Gore and Rob Carter and John R Zalcberg and Ren{\'{e}}e Otmar and Julian Savulescu},
  journal   = {The Lancet Oncology},
  title     = {Accepting risk in the acceleration of drug development for rare cancers},
  year      = {2015},
  month     = {apr},
  number    = {4},
  pages     = {e190--e194},
  volume    = {16},
  doi       = {10.1016/s1470-2045(14)71153-2},
  publisher = {Elsevier {BV}},
}

@Article{KokkaliZervos2020,
  author    = {S. Kokkali-Zervos and A. Ardavanis and M. Panousieris and J. Duran and I. Boukovinas},
  journal   = {Annals of Oncology},
  title     = {1645P Real-world data on cabozantinib in advanced osteosarcoma and Ewing sarcoma - A study of the Hellenic Group of Sarcoma and Rare Cancers},
  year      = {2020},
  month     = {sep},
  pages     = {S984},
  volume    = {31},
  doi       = {10.1016/j.annonc.2020.08.1871},
  publisher = {Elsevier {BV}},
}

@Article{Saddoughi2016,
  author    = {Sahar A. Saddoughi and Jim Taswell and William S. Harmsen and Matthew L. Inra and Shanda H. Blackmon and Francis C. Nichols and Stephen D. Cassivi and Dennis A. Wigle and K. Robert Shen and Mark S. Allen},
  journal   = {The Annals of Thoracic Surgery},
  title     = {Surgical Resection of Rare Esophageal Cancers},
  year      = {2016},
  month     = {jan},
  number    = {1},
  pages     = {311--315},
  volume    = {101},
  doi       = {10.1016/j.athoracsur.2015.06.015},
  publisher = {Elsevier {BV}},
}

@Article{Shah2021,
  author    = {Harsh Shah and Amre Ghazzal and Dweep Barbhaya and William Weigold},
  journal   = {Journal of the American College of Cardiology},
  title     = {{RECURRENT} {PERICARDIAL} {EFFUSION}: {AN} {EARLY} {PRESENTATION} {OF} A {RARE} {CANCER}},
  year      = {2021},
  month     = {may},
  number    = {18},
  pages     = {2966},
  volume    = {77},
  doi       = {10.1016/s0735-1097(21)04321-7},
  publisher = {Elsevier {BV}},
}

@Article{Casali2019,
  author    = {P.G. Casali},
  journal   = {Annals of Oncology},
  title     = {Rare cancers: from centralized referral to networking},
  year      = {2019},
  month     = {jul},
  number    = {7},
  pages     = {1037--1038},
  volume    = {30},
  doi       = {10.1093/annonc/mdz146},
  publisher = {Elsevier {BV}},
}

@Article{Griffiths2007,
  author     = {Jane Griffiths and Carole Willard and Andrea Burgess and Ziv Amir and Karen Luker},
  journal    = {European Journal of Oncology Nursing},
  title      = {Meeting the ongoing needs of survivors of rarer cancer},
  year       = {2007},
  month      = {dec},
  number     = {5},
  pages      = {434--441},
  volume     = {11},
  doi        = {10.1016/j.ejon.2007.09.004},
  publisher  = {Elsevier {BV}},
  readstatus = {read},
}

@Article{Tuffaha2018,
  author    = {H Tuffaha and P Scuffham},
  journal   = {Value in Health},
  title     = {Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia},
  year      = {2018},
  month     = {sep},
  pages     = {S110},
  volume    = {21},
  doi       = {10.1016/j.jval.2018.07.839},
  publisher = {Elsevier {BV}},
}

@Article{Majima2018,
  author    = {Yoshiyuki Majima},
  journal   = {Annals of Oncology},
  title     = {Patients expectation for drug discovery development targeting rare cancers},
  year      = {2018},
  month     = {oct},
  pages     = {vii36},
  volume    = {29},
  doi       = {10.1093/annonc/mdy386},
  publisher = {Elsevier {BV}},
}

@Article{Abdelshafy2018,
  author    = {M. Abdelshafy and Y. El Dakdouki and L. Verlingue and A. Hollebecque and L. Lacroix and S. Postel-Vinay and A. Varga and R. Balheda and J.-M. Michot and A. Marabelle and E. Rouleau and E. Solary and T. de Baere and E. Angevin and V. Ribrag and S. Michiels and F. Andr{\'{e}} and J.-Y. Scoazec and J.-C. Soria and C. Massard},
  journal   = {Annals of Oncology},
  title     = {Precision medicine for patients with rare cancers: An effective strategy within the prospective {MOSCATO} trial},
  year      = {2018},
  month     = {oct},
  pages     = {viii667},
  volume    = {29},
  doi       = {10.1093/annonc/mdy303.055},
  publisher = {Elsevier {BV}},
}

@Article{Noda2018,
  author    = {S. Noda and K. Yonemori and N. Shirakawa and H.S. Okuma and T. Shimizu and A. Hirakawa and T. Shibata and T. Sukigara and N. Okita and A. Kawai and N. Yamamoto and K. Nakamura and H. Mano and T. Nishida and Y. Fujiwara},
  journal   = {Annals of Oncology},
  title     = {{MASTER} {KEY} project: A basket/umbrella trial for rare cancers in Japan},
  year      = {2018},
  month     = {oct},
  pages     = {viii148},
  volume    = {29},
  doi       = {10.1093/annonc/mdy279.436},
  publisher = {Elsevier {BV}},
}

@Article{Stacchiotti2012,
  author    = {S. Stacchiotti and E. Palassini and R. Sanfilippo and B. Vincenzi and M.G. Arena and A.M. Bochicchio and P. De Rosa and A. Nuzzo and S. Turano and C. Morosi and A.P. Dei Tos and S. Pilotti and P.G. Casali},
  journal   = {Annals of Oncology},
  title     = {Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network},
  year      = {2012},
  month     = {feb},
  number    = {2},
  pages     = {501--508},
  volume    = {23},
  doi       = {10.1093/annonc/mdr066},
  publisher = {Elsevier {BV}},
}

@Article{Pasquier2015,
  author    = {David Pasquier and Brandon Barney and Santhanam Sundar and Philip Poortmans and Salvador Villa and Haitam Nasrallah and Noureddine Boujelbene and Pirus Ghadjar and Yasmin Lassen-Ramshad and El{\.{z}}bieta Senkus and Andrew Oar and Martine Roelandts and Maurizio Amichetti and Hansjoerg Vees and Thomas Zilli and Mahmut Ozsahin},
  journal   = {International Journal of Radiation Oncology{\ast}Biology{\ast}Physics},
  title     = {Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients},
  year      = {2015},
  month     = {jul},
  number    = {4},
  pages     = {904--910},
  volume    = {92},
  doi       = {10.1016/j.ijrobp.2015.03.019},
  publisher = {Elsevier {BV}},
}

@Article{Lancaster2005,
  author    = {C. Lancaster and M. Kokoris and M. Nabavi and J. Clemmens and P. Maloney and J. Capadanno and J. Gerdes and C.F. Battrell},
  journal   = {Methods},
  title     = {Rare cancer cell analyzer for whole blood applications: Microcytometer cell counting and sorting subcircuits},
  year      = {2005},
  month     = {sep},
  number    = {1},
  pages     = {120--127},
  volume    = {37},
  doi       = {10.1016/j.ymeth.2005.07.003},
  publisher = {Elsevier {BV}},
}

@Article{Shimoi2016,
  author    = {Tatsunori Shimoi and Kan Yonemori and Akira Kawai},
  journal   = {Annals of Oncology},
  title     = {Rare cancers$\mathsemicolon$ off label use},
  year      = {2016},
  month     = {nov},
  pages     = {vii44},
  volume    = {27},
  doi       = {10.1093/annonc/mdw489},
  publisher = {Elsevier {BV}},
}

@Article{Pierotti2009,
  author     = {Marco A. Pierotti and Tiziana Negri and Elena Tamborini and Federica Perrone and Sabrina Pricl and Silvana Pilotti},
  journal    = {Molecular Oncology},
  title      = {Targeted Therapies: The Rare Cancer Paradigm},
  year       = {2009},
  month      = {oct},
  number     = {1},
  pages      = {19--37},
  volume     = {4},
  doi        = {10.1016/j.molonc.2009.10.003},
  publisher  = {Wiley},
  readstatus = {read},
}

@Article{Pui2016,
  author    = {Ching-Hon Pui and Alberto Pappo and Amar Gajjar and James R Downing},
  journal   = {The Lancet Oncology},
  title     = {Redefining {\textquotedblleft}rare{\textquotedblright} in paediatric cancers},
  year      = {2016},
  month     = {feb},
  number    = {2},
  pages     = {138--139},
  volume    = {17},
  doi       = {10.1016/s1470-2045(15)00538-0},
  publisher = {Elsevier {BV}},
}

@Article{Prasad2015,
  author    = {Vinay Prasad and Andrew Oseran},
  journal   = {European Journal of Cancer},
  title     = {Do we need randomised trials for rare cancers?},
  year      = {2015},
  month     = {jul},
  number    = {11},
  pages     = {1355--1357},
  volume    = {51},
  doi       = {10.1016/j.ejca.2015.04.015},
  publisher = {Elsevier {BV}},
}

@Article{Sandrucci2015,
  author    = {S. Sandrucci and G. Gatta and A. Trama and A.P. Dei Tos and P.G. Casali},
  journal   = {European Journal of Surgical Oncology ({EJSO})},
  title     = {Specialized teams or specialist networks for rare cancers?},
  year      = {2015},
  month     = {sep},
  number    = {9},
  pages     = {1115--1117},
  volume    = {41},
  doi       = {10.1016/j.ejso.2015.04.002},
  publisher = {Elsevier {BV}},
}

@Article{Sklan2014,
  author    = {Alexandra Sklan},
  journal   = {The Lancet Oncology},
  title     = {Inadequate funding for rare cancers in Australia},
  year      = {2014},
  month     = {nov},
  number    = {12},
  pages     = {e534},
  volume    = {15},
  doi       = {10.1016/s1470-2045(14)70497-8},
  publisher = {Elsevier {BV}},
}

@Article{IrmingerFinger2014,
  author    = {Irmgard Irminger-Finger and Joanna Kargul and Geoff J. Laurent},
  journal   = {The International Journal of Biochemistry {\&}amp$\mathsemicolon$ Cell Biology},
  title     = {Rare cancers: What we can learn from them},
  year      = {2014},
  month     = {aug},
  pages     = {459--460},
  volume    = {53},
  doi       = {10.1016/j.biocel.2014.07.001},
  publisher = {Elsevier {BV}},
}

@Article{Casali2014,
  author    = {P.G. Casali},
  journal   = {Annals of Oncology},
  title     = {Rare cancers: work in progress in Europe},
  year      = {2014},
  month     = {apr},
  number    = {4},
  pages     = {914},
  volume    = {25},
  doi       = {10.1093/annonc/mdu033},
  publisher = {Elsevier {BV}},
}

@Article{Andrews2016,
  author    = {Elizabeth B. Andrews and Alicia Gilsenan and Kirk Midkiff and David Harris},
  journal   = {Annals of Epidemiology},
  title     = {Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcoma},
  year      = {2016},
  month     = {nov},
  number    = {11},
  pages     = {751--753},
  volume    = {26},
  doi       = {10.1016/j.annepidem.2016.08.011},
  publisher = {Elsevier {BV}},
}

@Article{Casali2010,
  author    = {Paolo G Casali},
  journal   = {The Lancet Oncology},
  title     = {Do rare cancers deserve specific strategies for cancer research?},
  year      = {2010},
  month     = {jun},
  number    = {6},
  pages     = {506--507},
  volume    = {11},
  doi       = {10.1016/s1470-2045(10)70099-1},
  publisher = {Elsevier {BV}},
}

@Article{Feldmeyer2013,
  author    = {Laurence Feldmeyer and Olivier Gaide and Daniel E. Speiser},
  journal   = {Journal of Investigative Dermatology},
  title     = {Clinical Implications of {CD}8$\mathplus$ T-Cell Infiltration in Frequent and Rare Cancers},
  year      = {2013},
  month     = {aug},
  number    = {8},
  pages     = {1929--1932},
  volume    = {133},
  doi       = {10.1038/jid.2013.90},
  publisher = {Elsevier {BV}},
}

@Article{Gronchi2016,
  author    = {Alessandro Gronchi and Rick L. Haas and Sylvie Bonvalot},
  journal   = {European Journal of Cancer},
  title     = {Cancer registries and randomised clinical trials in rare tumours: At the two extremes of daily clinical practice},
  year      = {2016},
  month     = {sep},
  pages     = {113--115},
  volume    = {64},
  doi       = {10.1016/j.ejca.2016.05.025},
  publisher = {Elsevier {BV}},
}

@Article{Porta2012,
  author    = {Camillo Porta},
  journal   = {European Urology},
  title     = {How to Identify Active Novel Agents in Rare Cancers and then Make Them Available: A Need for a Paradigm Shift},
  year      = {2012},
  month     = {dec},
  number    = {6},
  pages     = {1020--1021},
  volume    = {62},
  doi       = {10.1016/j.eururo.2012.07.035},
  publisher = {Elsevier {BV}},
}

@Article{Aggarwal2011,
  author    = {S. Aggarwal},
  journal   = {Value in Health},
  title     = {{PCN}24 Budget Impact Model for Rare Cancer Treatment: Case in Point Cutaneous T-Cell Lymphoma},
  year      = {2011},
  month     = {nov},
  number    = {7},
  pages     = {A438},
  volume    = {14},
  doi       = {10.1016/j.jval.2011.08.1125},
  publisher = {Elsevier {BV}},
}

@Article{Ellis2010,
  author    = {Libby Ellis and Jesme Fox and Michael D. Peake and Michel P. Coleman},
  journal   = {Lung Cancer},
  title     = {Lung cancer in young women remains rare},
  year      = {2010},
  month     = {jan},
  number    = {1},
  pages     = {124--125},
  volume    = {67},
  doi       = {10.1016/j.lungcan.2009.10.019},
  publisher = {Elsevier {BV}},
}

@Article{Bisoqno2011,
  author    = {G. Bisoqno},
  journal   = {European Journal of Cancer},
  title     = {105 {INVITED} Very Rare Cancers in Children {\textendash} From {TREP} to {EXPeRT}},
  year      = {2011},
  month     = {sep},
  pages     = {S27},
  volume    = {47},
  doi       = {10.1016/s0959-8049(11)70320-3},
  publisher = {Elsevier {BV}},
}

@Article{2011,
  journal   = {European Journal of Cancer},
  title     = {182 {INVITED} Paedatrics as Model of Centralising Treatment of Rare Cancers},
  year      = {2011},
  month     = {sep},
  pages     = {S43},
  volume    = {47},
  doi       = {10.1016/s0959-8049(11)70397-5},
  publisher = {Elsevier {BV}},
}

@Article{Petrov2022,
  author     = {Iurii Petrov and Andrey Alexeyenko},
  journal    = {{eLife}},
  title      = {Individualized discovery of rare cancer drivers in global network context},
  year       = {2022},
  month      = {may},
  volume     = {11},
  doi        = {10.7554/elife.74010},
  publisher  = {{eLife} Sciences Publications, Ltd},
  readstatus = {skimmed},
}

@Article{Olischlaeger2022,
  author     = {Daphne L. T. Olischläger and Li Xiang Y. den Boer and Eline de Heus and Linda Brom and Desiree J. S. Dona and Heinz-Josef Klümpen and Christina M. Stapelfeldt and Saskia F. A. Duijts},
  journal    = {Disability and Rehabilitation},
  title      = {Rare cancer and return to work: experiences and needs of patients and (health care) professionals},
  year       = {2022},
  month      = {jul},
  pages      = {1--12},
  doi        = {10.1080/09638288.2022.2099589},
  publisher  = {Informa {UK} Limited},
  readstatus = {read},
}

@Article{Onega2022,
  author     = {Tracy Onega and Jennifer Alford-Teaster and Chris Leggett and Andrew Loehrer and Julie E. Weiss and Erika L. Moen and Catherine C. Pollack, and Fahui Wang},
  journal    = {The Journal of Rural Health},
  title      = {The interaction of rurality and rare cancers for travel time to cancer care},
  year       = {2022},
  month      = {jul},
  doi        = {10.1111/jrh.12693},
  publisher  = {Wiley},
  readstatus = {read},
}

@Article{Srinivas2021,
  author    = {Sujay Srinivas and Jyoti Bajpai},
  journal   = {Journal of Immunotherapy and Precision Oncology},
  title     = {Checkpoint Inhibitors in Checkmating Rare Cancers},
  year      = {2021},
  month     = {apr},
  number    = {4},
  pages     = {178--179},
  volume    = {4},
  doi       = {10.36401/jipo-20-x10},
  publisher = {Innovative Healthcare Institute},
}

@InProceedings{Delikoyun2021,
  author    = {Kerem Delikoyun and Ali Aslan Demir and Huseyin Cumhur Tekin},
  booktitle = {Label-free Biomedical Imaging and Sensing ({LBIS}) 2021},
  title     = {Label-free detection of rare cancer cells using deep learning and magnetic levitation principle},
  year      = {2021},
  editor    = {Natan T. Shaked and Oliver Hayden},
  month     = {mar},
  publisher = {{SPIE}},
  doi       = {10.1117/12.2572908},
}

@Article{Liontos2020,
  author    = {Michalis Liontos and Evangelos Karamitrousis and Nikolaos Tsoukalas and Ioannis Boukovinas},
  journal   = {Forum of Clinical Oncology},
  title     = {Rare cancers are common: time to act},
  year      = {2020},
  month     = {dec},
  number    = {3},
  pages     = {1--2},
  volume    = {11},
  doi       = {10.2478/fco-2019-0024},
  publisher = {Walter de Gruyter {GmbH}},
}

@Article{Krendyukov2021,
  author    = {Andriy Krendyukov and Sanjay Singhvi and Markus Zabransky},
  journal   = {Frontiers in Oncology},
  title     = {Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers},
  year      = {2021},
  month     = {mar},
  volume    = {11},
  doi       = {10.3389/fonc.2021.636561},
  publisher = {Frontiers Media {SA}},
}

@Article{Kondo2021,
  author    = {Tadashi Kondo},
  journal   = {Cancer Science},
  title     = {Current status and future outlook for patient-derived cancer models from a rare cancer research perspective},
  year      = {2021},
  month     = {feb},
  number    = {3},
  pages     = {953--961},
  volume    = {112},
  doi       = {10.1111/cas.14669},
  publisher = {Wiley},
}

@Article{Koyyala2020,
  author    = {Venkata Pradeep Babu Koyyala and Padmaj Kulkarni},
  journal   = {Indian Journal of Medical and Paediatric Oncology},
  title     = {Immunotherapy in Rare Cancers},
  year      = {2020},
  month     = {nov},
  number    = {06},
  pages     = {801--803},
  volume    = {41},
  doi       = {10.4103/ijmpo.ijmpo_234_20},
  publisher = {Georg Thieme Verlag {KG}},
}

@Article{Lynge2020,
  author    = {Elsebeth Lynge and Linda Kaerlev and J{\o}rn Olsen and Svend Sabroe and Noemia Afonso and Wolfgang Ahrens and Mikael Eriksson and Franco Merletti and Maria Morales-Suarez-Varelas and Aivars Stengrevics and Pascal Gu{\'{e}}nel},
  journal   = {European Journal of Epidemiology},
  title     = {Rare cancers of unknown etiology: lessons learned from a European multi-center case{\textendash}control study},
  year      = {2020},
  month     = {jul},
  number    = {10},
  pages     = {937--948},
  volume    = {35},
  doi       = {10.1007/s10654-020-00663-y},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{OConnor2020,
  author    = {Daniel J O'Connor},
  journal   = {Expert Opinion on Orphan Drugs},
  title     = {Rare cancers, the continued agenda for progress {\textendash} editor's special foreword},
  year      = {2020},
  month     = {sep},
  number    = {9},
  pages     = {309--310},
  volume    = {8},
  doi       = {10.1080/21678707.2020.1821529},
  publisher = {Informa {UK} Limited},
}

﻿Scopus
EXPORT DATE: 23 August 2022

@Article{Darling2020,
  author            = {Darling, H.S. and Rastogi, Sameer},
  journal           = {Indian Journal of Cancer},
  title             = {Rare cancers in India: A road less travelled},
  year              = {2020},
  note              = {Cited by: 3},
  number            = {2},
  pages             = {139 – 143},
  volume            = {57},
  doi               = {10.4103/ijc.IJC-384-19},
  publication_stage = {Final},
  url               = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085242767&doi=10.4103%2fijc.IJC-384-19&partnerID=40&md5=e0081f2e99af20a09bba53b36ddfe165},
}

@Article{Kwak2020,
  author    = {Jung-Myun Kwak},
  journal   = {Annals of Coloproctology},
  title     = {Acknowledging the Unsung Role of the Cancer Registry in Rare Cancers},
  year      = {2020},
  month     = {feb},
  number    = {1},
  pages     = {1--2},
  volume    = {36},
  doi       = {10.3393/ac.2020.02.11},
  publisher = {Korean Society of Coloproctology},
}

@Article{Balmant2019,
  author    = {Nathalie V. Balmant and Rejane de Souza Reis and Marceli de Oliveira Santos and Beatriz de Camargo and Gemma Gatta},
  journal   = {Cancer},
  title     = {Rare cancers in childhood and adolescence in Brazil: First report of data from 19 population-based cancer registries},
  year      = {2019},
  month     = {apr},
  doi       = {10.1002/cncr.32121},
  publisher = {Wiley},
}

@Article{Jain2019,
  author    = {Rahul Jain and Joseph Menzin and Kristina Lachance and Patrick McBee and Hemant Phatak and Paul T. Nghiem},
  journal   = {Cancer Medicine},
  title     = {Travel burden associated with rare cancers: The example of Merkel cell carcinoma},
  year      = {2019},
  month     = {apr},
  number    = {5},
  pages     = {2580--2586},
  volume    = {8},
  doi       = {10.1002/cam4.2085},
  publisher = {Wiley},
}

@Article{Bell2019,
  author    = {Catherine Bell and Katie Kerr and Kerry Moore and Charlene McShane and Lesley Anderson and Amy Jayne McKnight and Helen McAneney},
  journal   = {Systematic Reviews},
  title     = {Communication strategies for rare cancers: a systematic review protocol},
  year      = {2019},
  month     = {apr},
  number    = {1},
  volume    = {8},
  doi       = {10.1186/s13643-019-1017-5},
  publisher = {Springer Science and Business Media {LLC}},
}

@InCollection{Demeure2019,
  author    = {Michael J. Demeure},
  booktitle = {Precision Medicine in Cancer Therapy},
  publisher = {Springer International Publishing},
  title     = {The Role of Precision Medicine in the Diagnosis and Treatment of Patients with Rare Cancers},
  year      = {2019},
  pages     = {81--108},
  doi       = {10.1007/978-3-030-16391-4_3},
}

@Article{Cohen2018,
  author    = {Deborah Cohen},
  journal   = {{BMJ}},
  title     = {Breast implants linked to rare cancer are removed from European market},
  year      = {2018},
  month     = {dec},
  pages     = {k5401},
  doi       = {10.1136/bmj.k5401},
  publisher = {{BMJ}},
}

@Article{Horick2018,
  author    = {Nora K. Horick and Ariela Muzikansky and Hilda L. Gutierrez and Kristina L. Boyd and Dianne M. Finkelstein},
  journal   = {Journal of Cancer Survivorship},
  title     = {Physical symptoms in long-term survivors of rare cancer},
  year      = {2018},
  month     = {oct},
  number    = {6},
  pages     = {835--842},
  volume    = {12},
  doi       = {10.1007/s11764-018-0721-9},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Bergerot2018,
  author    = {Cristiane Decat Bergerot and Paulo Gustavo Bergerot and Errol J. Philip and Edvane Birelo Lopes De Domenico and Maria Fernanda Marcusso Manhaes and Renata Nunes Pedras and Meghan M. Salgia and Nazli Dizman and Kimlin Tam Ashing and Min Li and William Dale and Sumanta K. Pal},
  journal   = {Psycho-Oncology},
  title     = {Assessment of distress and quality of life in rare cancers},
  year      = {2018},
  month     = {sep},
  number    = {12},
  pages     = {2740--2746},
  volume    = {27},
  doi       = {10.1002/pon.4873},
  publisher = {Wiley},
}

@Article{Kuenzel2017,
  author    = {Ulrike Kuenzel and Tabea Monga Sindeu and Sarah Schroth and Jutta Huebner and Natalie Herth},
  journal   = {Journal of Cancer Education},
  title     = {Evaluation of the Quality of Online Information for Patients with Rare Cancers: Thyroid Cancer},
  year      = {2017},
  month     = {jan},
  number    = {5},
  pages     = {960--966},
  volume    = {33},
  doi       = {10.1007/s13187-017-1173-z},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Lukic2018,
  author    = {Marko Lukic and Lena Maria Nilsson and Guri Skeie and Bernt Lindahl and Tonje Braaten},
  journal   = {European Journal of Epidemiology},
  title     = {Coffee consumption and risk of rare cancers in Scandinavian countries},
  year      = {2018},
  month     = {feb},
  number    = {3},
  pages     = {287--302},
  volume    = {33},
  doi       = {10.1007/s10654-018-0369-9},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Nicolazzo2018,
  author    = {Chiara Nicolazzo and Luciano Colangelo and Alessandro Corsi and Guido Carpino and Angela Gradilone and Chiara Sonato and Cristina Raimondi and Eugenio Gaudio and Paola Gazzaniga and Walter Gianni},
  journal   = {Analytical Cellular Pathology},
  title     = {Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma},
  year      = {2018},
  pages     = {1--4},
  volume    = {2018},
  doi       = {10.1155/2018/9718585},
  publisher = {Hindawi Limited},
}

@Article{Zwan2018,
  author    = {Jan M. van der Zwan and Boukje A.C. van Dijk and Otto Visser and Han J.H.J.M. van Krieken and Riccardo Capocaccia and Sabine Siesling},
  journal   = {European Journal of Cancer Prevention},
  title     = {Rare cancers in The Netherlands: a population-based study},
  year      = {2018},
  month     = {jul},
  number    = {4},
  pages     = {384--390},
  volume    = {27},
  doi       = {10.1097/cej.0000000000000166},
  publisher = {Ovid Technologies (Wolters Kluwer Health)},
}

@Article{Ledford2017,
  author    = {Heidi Ledford},
  journal   = {Nature},
  title     = {Century-old tumours offer rare cancer clues},
  year      = {2017},
  month     = {may},
  number    = {7654},
  pages     = {278--278},
  volume    = {545},
  doi       = {10.1038/nature.2017.21975},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Horick2016,
  author    = {Nora K. Horick and Adoma Manful and Jan Lowery and Susan Domchek and Patricia Moorman and Constance Griffin and Kala Visvanathan and Claudine Isaacs and Anita Y. Kinney and Dianne M. Finkelstein},
  journal   = {Journal of Cancer Survivorship},
  title     = {Physical and psychological health in rare cancer survivors},
  year      = {2016},
  month     = {oct},
  number    = {1},
  pages     = {158--165},
  volume    = {11},
  doi       = {10.1007/s11764-016-0573-0},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Ravindran2016,
  author    = {Aishwarya Ravindran and Wilson I. Gonsalves and Shahrukh K. Hashmi and Prashant Kapoor and Ariela L. Marshall and Mustaqeem A. Siddiqui and Ronald S. Go},
  journal   = {Leukemia {\&}amp$\mathsemicolon$ Lymphoma},
  title     = {Estimating the annual volume of hematologic cancer cases per hematologist{\textendash}oncologist in the United States: are we treating rare cancers too rarely?},
  year      = {2016},
  month     = {jun},
  number    = {1},
  pages     = {251--252},
  volume    = {58},
  doi       = {10.1080/10428194.2016.1193854},
  publisher = {Informa {UK} Limited},
}

@Article{Gronchi2016a,
  author    = {Alessandro Gronchi and Paolo Delrio and Vittorio Quagliuolo and Sergio Sandrucci},
  journal   = {Updates in Surgery},
  title     = {The Italian Society of Surgical Oncology ({SICO}) survey on the minimum requirements of rare cancers referral centers},
  year      = {2016},
  month     = {jun},
  number    = {4},
  pages     = {321--323},
  volume    = {68},
  doi       = {10.1007/s13304-016-0376-x},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Brade2016,
  author    = {Anthony M. Brade and Laura Ann Dawson},
  journal   = {Journal of Clinical Oncology},
  title     = {To {RCT} or Not to {RCT}: How to Change Practice for Rare Cancers?},
  year      = {2016},
  month     = {jan},
  number    = {3},
  pages     = {203--204},
  volume    = {34},
  doi       = {10.1200/jco.2015.63.8767},
  publisher = {American Society of Clinical Oncology ({ASCO})},
}

@InCollection{Jacobs2016,
  author    = {Chris Jacobs and Gabriella Pichert},
  booktitle = {Recent Results in Cancer Research},
  publisher = {Springer International Publishing},
  title     = {Genetic Testing for Rare Cancer: The Wider Issues},
  year      = {2016},
  pages     = {213--226},
  doi       = {10.1007/978-3-319-29998-3_12},
}

@Article{Mayor2016,
  author    = {Susan Mayor},
  journal   = {{BMJ}},
  title     = {A quarter of patients with rarer cancers see {GPs} several times before referral},
  year      = {2016},
  month     = {feb},
  pages     = {i1198},
  doi       = {10.1136/bmj.i1198},
  publisher = {{BMJ}},
}

@Article{Olver2015,
  author    = {Ian N Olver},
  journal   = {Medical Journal of Australia},
  title     = {Reassessing rare cancers},
  year      = {2015},
  month     = {nov},
  number    = {10},
  pages     = {386--386},
  volume    = {203},
  doi       = {10.5694/mja15.00974},
  publisher = {{AMPCo}},
}

@Article{Loggers2014,
  author    = {Elizabeth Trice Loggers and Holly G. Prigerson},
  journal   = {Rare Tumors},
  title     = {The End-of-Life Experience of Patients with Rare Cancers and their Caregivers},
  year      = {2014},
  month     = {mar},
  number    = {1},
  pages     = {24--27},
  volume    = {6},
  doi       = {10.4081/rt.2014.5281},
  publisher = {{SAGE} Publications},
}

@Article{Kondrashova201541,
  author            = {Kondrashova, Olga and Waring, Paul},
  journal           = {Cancer Forum},
  title             = {Is genomics making rare cancers common and common cancers rare?},
  year              = {2015},
  note              = {Cited by: 1},
  number            = {1},
  pages             = {41 – 43},
  volume            = {39},
  publication_stage = {Final},
  url               = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923626261&partnerID=40&md5=f8a65b131414b7289a69169be01efd6f},
}

@Article{Casali2015,
  author    = {P.G. Casali and P. Bruzzi and J. Bogaerts and J.-Y. Blay and M. Aapro and A. Adamous and A. Berruti and J.-Y. Blay and J. Bogaerts and J. Bressington and B. Bruzzi and R. Capocaccia and F. Cardoso and P.G. Casali and J.E. Celis and A. Cervantes and F. Ciardiello and C. Claussen and M. Coleman and S. Comis and S. Craine and D. De Boltz and F. De Lorenzo and A.P. Dei Tos and G. Gatta and J. Geissler and R. Giuliani and E. Grande and A. Gronchi and S. Jezdic and B. Jonsson and L. Jost and H. Keulen and D. Lacombe and G. Lamory and Y. Le Cam and S. Leto di Priolo and L. Licitra and F. Macchia and A. Margulies and S. Marreaud and G. McVie and S. Narbutas and K. Oliver and N. Pavlidis and J. Pelouchova and G. Pentheroudakis and M. Piccart and M.A. Pierotti and G. Pravettoni and K. Redmond and P. Riegman and M.P. Ruffilli and D. Ryner and S. Sandrucci and M. Seymour and V. Torri and A. Trama and S. Van Belle and G. Vassal and M. Wartenberg and C. Watts and A. Wilson and W. Yared},
  journal   = {Annals of Oncology},
  title     = {Rare Cancers Europe ({RCE}) methodological recommendations for clinical studies in rare cancers: a European consensus position paper},
  year      = {2015},
  month     = {feb},
  number    = {2},
  pages     = {300--306},
  volume    = {26},
  doi       = {10.1093/annonc/mdu459},
  publisher = {Elsevier {BV}},
}

@Article{Abel2015,
  author    = {G A Abel and J Shelton and S Johnson and L Elliss-Brookes and G Lyratzopoulos},
  journal   = {British Journal of Cancer},
  title     = {Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers},
  year      = {2015},
  month     = {mar},
  number    = {S1},
  pages     = {S129--S136},
  volume    = {112},
  doi       = {10.1038/bjc.2015.52},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{Shin2015,
  author    = {Dong Wook Shin and Juhee Cho and Hyung Kook Yang and So Young Kim and Su Hyun Lee and Beomseok Suh and Hee-Young Shin and Hyun Joo Lee and Dae Ghon Kim and Jong Hyock Park},
  journal   = {Cancer Research and Treatment},
  title     = {Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey},
  year      = {2015},
  month     = {jan},
  number    = {4},
  pages     = {591--599},
  volume    = {47},
  doi       = {10.4143/crt.2014.086},
  publisher = {Korean Cancer Association},
}

@Article{Lynge2005,
  author     = {Elsebeth Lynge and Noemia Afonso and Linda Kaerlev and J{\o}rn Olsen and Svend Sabroe and Wolfgang Ahrens and Mikael Eriksson and Pascal Gu{\'{e}}nel and Franco Merletti and Aivars Stengrevics and Maria Suarez-Varela and Altamiro Costa-Pererra and Mogens Vyberg},
  journal    = {European Journal of Cancer},
  title      = {European multi-centre case{\textendash}control study on risk factors for rare cancers of unknown aetiology},
  year       = {2005},
  month      = {mar},
  number     = {4},
  pages      = {601--612},
  volume     = {41},
  doi        = {10.1016/j.ejca.2004.12.016},
  publisher  = {Elsevier {BV}},
  readstatus = {read},
}

@Article{Marty2008,
  author    = {M. Marty and N. Rheims},
  journal   = {Oncologie},
  title     = {Cancers rares : des entit{\'{e}}s diff{\'{e}}rentes, des probl{\'{e}}matiques communes},
  year      = {2008},
  month     = {jun},
  number    = {6},
  pages     = {360--362},
  volume    = {10},
  doi       = {10.1007/s10269-008-0894-3},
  publisher = {Computers, Materials and Continua (Tech Science Press)},
}

@Article{Grant2010,
  author    = {W. B. Grant},
  journal   = {American Journal of Epidemiology},
  title     = {Re: "Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers"},
  year      = {2010},
  month     = {sep},
  number    = {10},
  pages     = {1210--1211},
  volume    = {172},
  doi       = {10.1093/aje/kwq301},
  publisher = {Oxford University Press ({OUP})},
}

@Article{Gaddipati2012,
  author    = {Himabindu Gaddipati and Ke Liu and Anne Pariser and Richard Pazdur},
  journal   = {Clinical Cancer Research},
  title     = {Rare Cancer Trial Design: Lessons from {FDA} Approvals},
  year      = {2012},
  month     = {sep},
  number    = {19},
  pages     = {5172--5178},
  volume    = {18},
  doi       = {10.1158/1078-0432.ccr-12-1135},
  publisher = {American Association for Cancer Research ({AACR})},
}

@Article{Zlatareva201513,
  author            = {Zlatareva, Al. and Petrova, G.},
  journal           = {General Medicine},
  title             = {National health insurance fund cost analysis for rare cancer diseases and orphan drugs},
  year              = {2015},
  note              = {Cited by: 0},
  number            = {1},
  pages             = {13 – 18},
  volume            = {17},
  publication_stage = {Final},
  url               = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929159214&partnerID=40&md5=a53f2886ae5939d5c587f17fd90dae18},
}

@Article{Guenel2004,
  author    = {Pascal Gu{\'{e}}nel and Diane Cyr and Svend Sabroe and Elsebeth Lynge and Franco Merletti and Wolfgang Ahrens and Cornelia Baumgardt-Elms and Fran{\c{c}}ois M{\'{e}}n{\'{e}}goz and H{\aa}kan Olsson and Stein Paulsen and Lorenzo Simonato and Gun Wingren},
  journal   = {Cancer Causes {\&}amp$\mathsemicolon$ Control},
  title     = {Alcohol Drinking May Increase Risk of Breast Cancer in Men: A European Population-Based Case{\textendash}Control Study},
  year      = {2004},
  month     = {aug},
  number    = {6},
  pages     = {571--580},
  volume    = {15},
  doi       = {10.1023/b:caco.0000036154.18162.43},
  publisher = {Springer Science and Business Media {LLC}},
}

@Article{10.2307/44996559,
  author    = {Maria M. Morales-Suárez-Varela and Jorn Olsen and Preben Johansen and Linda Kaerlev and Pascal Guénel and Patrick Arveux and Gun Wingren and Lennart Hardell and Wolfgang Ahrens and Andreas Stang and Agustin Llopis and Franco Merletti and Juan Jose Aurrekoetxea and Giovanna Masala},
  journal   = {Journal of Occupational and Environmental Medicine},
  title     = {Occupational Risk Factors for Mycosis Fungoides: A European Multicenter Case-Control Study},
  year      = {2004},
  issn      = {10762752, 15365948},
  number    = {3},
  pages     = {205--211},
  volume    = {46},
  abstract  = {Mycosis fungoides (MF) is a rare disease with an unknown etiology. Its distribution suggests that occupational exposures may play a role. In the present study, we searched for occupational factors associated with MF. A European multicenter case-control study on seven rare cancers, including MF, was conducted from 1995 to 1997. Patients between 35 and 69 years of age diagnosed with MF (n = 134) were identified and their diagnoses were checked by a reference pathologist who classified 83 cases as definitive, 35 cases as possible, and 16 cases as not histologically verified Of the 118 histologically verified cases, 104 were interviewed, of which 76 were definitive cases. As controls, we selected population controls and colon cancer controls to serve all seven case groups. Altogether, 833 colon cancer controls and 2071 population controls were interviewed. The response rate was 91.5% for cases (76 of the 83 definitive cases), and 66.6% for controls. A high risk of MF for men was observed in the industries of other non-metallic mineral products (Odds Ratio [OR] 5.3, 95% confidence interval [CI] = 1.7-16.2) and of wholesale trade (OR 3.6, 95% CI = 1.3-10.5). A high risk was found for female employees in the sector of pulp paper manufacture (OR 14.4, 95% CI = 2.2-95.1). The male occupations with the highest risks were glass formers, potters, and ceramics workers (OR 17.9, 95% CI = 5.4-59.4) and technical salesmen (OR 8.6, 95% CI = 2.4-30.8). For women, the occupations associated with the highest risks were government executives (OR 4.8, 95% CI = 1.0-22.6) and railway and road vehicles loaders (OR 3.9, 95% CI = 1.0-14.0). The results suggest that some occupational factors are associated with MF. Working as glass formers, pottery, and ceramics workers carried the highest risk, and these findings deserve further attention and replication. Females working in the paper and pulp industries may also be exposed to carcinogens of relevance to MF.},
  publisher = {Lippincott Williams & Wilkins},
  url       = {http://www.jstor.org/stable/44996559},
  urldate   = {2022-08-24},
}

@Article{Kaerlev2002,
  author    = {Linda Kaerlev and Peter Stubbe Teglbjaerg and Svend Sabroe and Henrik A. Kolstad and Wolfgang Ahrens and Mikael Eriksson and Pascal Gu??nel and Lennart Hardell and Diane Cyr and Terri Ballard and Paola Zambon and Mar??a M. Morales Su??rez-Varela and Andreas Stang and Jorn Olsen},
  journal   = {Journal of Occupational and Environmental Medicine},
  title     = {Occupational Risk Factors for Small Bowel Carcinoid Tumor: A European Population-Based Case-Control Study},
  year      = {2002},
  month     = {jun},
  number    = {6},
  pages     = {516--522},
  volume    = {44},
  doi       = {10.1097/00043764-200206000-00012},
  publisher = {Ovid Technologies (Wolters Kluwer Health)},
}

@Article{L.Kaerlev2001,
  author    = {L. Kaerlev, P. Stubbe Teglbjaerg, S},
  journal   = {Scandinavian Journal of Gastroenterology},
  title     = {Medical Risk Factors for Small-Bowel Adenocarcinoma with Focus on Crohn Disease: A European Population-based Case-Control Study},
  year      = {2001},
  month     = {jan},
  number    = {6},
  pages     = {641--646},
  volume    = {36},
  doi       = {10.1080/00365520118247},
  publisher = {Informa {UK} Limited},
}

@Article{Chabner1992,
  author    = {Bruce A. Chabner and Michael A. Friedman},
  journal   = {New England Journal of Medicine},
  title     = {Progress against Rare and Not-So-Rare Cancers},
  year      = {1992},
  month     = {feb},
  number    = {8},
  pages     = {563--565},
  volume    = {326},
  doi       = {10.1056/nejm199202203260811},
  publisher = {Massachusetts Medical Society},
}

@Article{rare_agenda2030,
  author  = {Casali,Paolo},
  title   = {RARE CANCER AGENDA 2030 Ten Recommendations from the EU Joint Action on Rare Cancers},
  ranking = {rank5},
  url     = {https://siope.eu/media/documents/rare-cancer-agenda-2030.pdf},
}

@Comment{jabref-meta: databaseType:bibtex;}

@Comment{jabref-meta: fileDirectoryLatex-Latitude E7270-PC:C:\\Users\\Latitude E7270\\Documents\\MEGAsync\\phd\\phd;}
